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RESUMEN 
 
La muerte celular dependiente de lisosoma es un tipo de muerte en el que la estabilidad de 
la membrana se pierde, llevando a la liberación del contenido lisosomal al citosol. Parte de 
las proteínas del lumen lisosomal son activas en el citosol, lo que desencadena el corte de 
múltiples proteínas citoplasmaticas, llevando a muerte celular. Además, la autofagia, 
mecanismo necesario para la homeostasis celular, requiere de lisosomas en correcto estado 
para poder ser efectiva. En esta tesis, el papel de la autofagia y la estabilidad lisosomal fue 
estudiado en un modelo murino de degeneración retiniana llamado retinitis pigmentaria, 
demonstrando que en un modelo de ratón de esta enfermedad, la muerte celular 
dependiente de lisosoma está ocurriendo. Estos resultados nos llevaron a estudiar el 
mecanismo de esta muerte en modelos deficientes de autofagia, descubriendo que la 
proteína Atg7, necesaria para la inducción de la autofagia, podría tener un papel 
fundamental en la composición lipídica del lisosoma, afectando directamente a la 
estabilidad lisosomal. 
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ABSTRACT 
 
Lysosomal-dependent cell death is a kind of cell death which is characterized by the lost of 
the lysosomal stability, leading to the release of the lysosomal content to the cytosol. Some 
of the lyososomal protein are active in the cytosol, leading to the cleavage of several 
cytoplasmic proteins, promoting cell death. In addition, autophagy, which is a necessary 
mechanism for the cellular homeostasis, needs functional lysosomes to be effective. In this 
thesis, autophagy role and lysosomal stability was studied in a mouse model of a retinal 
degeneration disease called retinitis pigmentosa, demonstrating that in this model of the 
disease, lysosomal dependent-cell death is happening. These results leaded us to study this 
cell death mechanism in autophagy-deficient models, demonstrating that the protein Atg7, 
necessary for autophagy induction, could present a fundamental role in the lysosomal 
lipidic composition, afecting to the lysosomal stability.  
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ABBREVIATIONS 
 
ADCD: autophagy-dependent cell death 
AMD: Age-Related Macular 
Degeneration 
BafA1: Bafilomycin A1 
BMP: bis(monoacylglycero)phosphate 
BSA: bovine serum albumin 
CAD: cationic amphiphilic drug 
CMA: chaperone-mediated autophagy 
DAPI: 1,4-diamino-2-fenilindol 
DTT: dithiothreitol 
FBS: fetal bovine serum 
GCL: ganglionar cell layer 
INL: inner nuclear layer 
IPL: inner plexiform layer 
LDCD: lysosome-dependent cell death 
LMP: lysosomal membrane 
permeabilization 
 
 
LLOMe : Leu-Leu-OMe 
LSD : lysosomal storage disorder 
LTR: LysoTracker Red 
MMP : mitochondrial membrane 
permeabilization 
MPP+: neurotoxin 1-methyl-4-
phenylpyridinium  
MTDR: MitoTracker Deep Red 
NGS: normal goat serum 
ONL: outer nuclear layer 
OPL: outer plexiform layer 
PAS: pre-autophagosome structure  
PBS: phosphate buffer saline 
PE: phosphatidylethanolamine 
PFA: paraformaldehyde 
ROS: Reactive Oxidative Species 
SDS: Sodium Dodecyl Sulfate 
TSA: trichostatin A 
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1. INTRODUCTION 
 
1.1 AUTOPHAGY 
 
Autophagy is a term formed by two Greek words: “auto” means “self”; “phagy” means 
“eating”. In that way, “autophagy” or “self-eating” is the mechanism that cells use to 
degrade and recycle intracellular components including proteins and even whole organelles 
by delivering and degrading them inside lysosomes. (Boya et al., 2013). Three types of 
autophagy have been described, depending on the way the intracellular material is 
delivered to lysosomes: macroautophagy, chaperone-mediated autophagy or 
microautophagy (Figure 1.1). 
 
Macroautophagy is the best well known type of autophagy. During the macroautophagy, 
the formation of the double-membrane vesicles is mandatory. This structure is called 
autophagosome and it is in charge of sequestering components to be degraded. Finally, 
autophagosome fusses with lysosome. Several proteins are implicated in this mechanism. 
This thesis will go in deep later into this type of autophagy. 
 
Chaperone-mediated autophagy (CMA) is a selective type of autophagy where the 
proteins with KFERQ-like pentatide motif are recognized by the chaperone Hsc70 and 
delivered to the lysosomes (Cuervo and Dice 1996). The translocation of the proteins to the 
lysosomal lumen needs channels generated by the lysosomal-associated membrane protein 
type 2A (Lamp2A) and the presence of the chaperone heat shock chaperone 70 (Hsc70) 
(Salvador et al., 2000). Interestingly, this type of autophagy only occurs in mammalian 
cells.  
 
In mammals, microautophagy is the less characterized type of autophagy. This system, 
only present in yeast, implies the invagination of the lysosomal membrane to imbibe the 
compounds to degrade (Sahu et al., 2011). There are two types of microautophagy: non-
selective, which degrade portions of cytosol randomly; or selective, degrading specific 
organelles: micromitophagy (mitochondrias), micronucleophagy (nucleus), or 
micropexophagy (peroxisomes) (Mijaljica et al., 2011). 
Introduction 
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Figure 1.1. Types of autophagy. (A) Macroautophagy, characterized by the formation of autophagosomes. 
(B) Chaperone-mediated autophagy (CMA), the proteins with the KFERQ motif are recognized and carried 
to the lysosome. (C) Microautophagy, direct invagination of the lysosomes of the compounds to degrade. 
Figure taken from Boya et al., 2013. 
 
Autophagy can be non-selective, when autophagy degrades bulk cytoplasm to recycle 
compounds and get energy to survive to unfavorable situations, such as starvation; or 
highly selective, when autophagy targets specifically intracellular components such as 
organelles and intracellular bacteria. This type of autophagy has promoted a new 
understanding of this process due to the new roles that it can present. For example, 
controlled mitophagy (mitochondrial-specific autophagy) promotes a metabolic switch 
during retinal development (Esteban-Martinez et al., 2017). Selective autophagy is 
described further (apart 1.1.1.2). 
 
 
1.1.1 Macroautophagy 
 
Hereinafter, this book will refer to macroautophagy simply as autophagy. Christian de 
Duve discovered autophagy due to his observations in rat liver where he studied cellular 
enzymes, identifying a novel intracellular granule that he called “lysosome” (De Duve et 
al., 1955). Subsequent experiments performed later by Prof. Yoshinori Ohsumi of 
defective mutants in the yeast Saccharomyces cerevisiae promoted the discovery of the 
Introduction 
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proteins implicated in this degradation process (Tsukada and Ohsumi, 1993).  For these 
discoveries, Yoshinori Ohsumi was awarded with the Nobel Prize in the year 2016. 
Ohsumi thought that, if autophagy was happening in yeast, inhibition of vacuolar enzymes 
would result in the accumulation of cytoplasmic vacuoles. He created random mutants of 
the vacuolar proteases to identify the phenotype of vacuolar accumulation, discovering the 
proteins implicated in autophagy in yeast (Takeshige et al., 1992; Tsukada and Ohsumi, 
1993). The proteins that he found have been conserved through the eukaryotic evolution 
(Feng et al., 2013), pointing out the importance of this process. However, several genes 
appear in mammals and not in yeast, indicating the increase in the complexity of the 
system and the addition of new functions. In addition, proteomic analysis demonstrated the 
complexity of the interaction between the proteins implicated in autophagy (Behrends et 
al., 2010).  Nowadays, 40 autophagy-related genes are known in yeast (Liu et al., 2017), 
considering genes implicated in the regulation and machinery of autophagy, as well as 
genes implicated in the selective autophagy, such as receptors. Nevertheless, the 
autophagy-related proteins are implicated in other mechanisms in the cellular homeostasis 
(as this book will explain in the apart 1.1.1.3).  
 
Autophagy is characterized by the formation of autophagosomes. These autophagosomes 
are transient organelles, with a half-life of 10 minutes before fussing with the lysosome. 
Due to the dynamism of this process, the exploration of autophagy has been an arduous 
challenge to researchers. The inhibition of the lysosomal activity and discovery of a 
specific marker of the autophagosome (Kabeya et al., 2000), together with the ability to 
perform ATG-specific mutants has busted research in this field (Ohsumi, 2014).  
 
1.1.1.1 Macroautophagy phases 
 
Autophagy process is divided in several phases: autophagy induction, nucleation and 
elongation of the autophagosomal membrane; fusion with lysosome and recycling of the 
compounds obtained after the degradation (figure 1.2). 
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Figure 1.2. Macroautophagy phases. Induction and nucleation of the autophagosome are the first steps of 
macroautophagy. Then, autophagosome expansion and closure need to happen to degrade the obsolete 
material. The last step is the fusion of autophagosome with lysosome to degrade the compounds to recycle, 
such as sugars, amino acids, fatty acids or nucleotides. Figure taken from Galluzi et al., 2015. 
 
Before the induction of autophagy, several kinases such as TOR (mTOR in mammals) or 
AMP-activated protein kinase (AMPK) are in charge of regulating this process. TOR is 
able to inhibit to the initiation complex, formed by Atg1-Atg13-Atg17 in yeast. Atg13 is 
hyperphosphorylated under nutrients-presence conditions by TOR complex. But, Atg13 is 
dephosphorylated when autophagy is induced (Scott et al., 2000). In mammals, the 
complex ULK1/2, homolog of Atg1, interacts with Atg13. ULK1 can be activated by 
(AMPK)-dependent process (glucose starvation) or AMPK-independent process (amino 
acid starvation). When this happens, mTOR1 complex phosphorylates ULK1/2 and Atg13, 
avoiding the interaction between ULK1 and AMPK. But, in starvation, mTOR is released 
from this complex, leading to the activation of ULK1/2. Ambra1 and Beclin1 are also 
phosphorylated by ULK1. These interactions promote the localization of these proteins to 
the autophagosome formation (Kim et al., 2011).  
 
During autophagosome nucleation in yeast, Atg9 is a transmembrane protein that is 
present in sites in membranes where the double membrane begins its formation. This 
double membrane is called phagophore is going to appear. The mammalian homolog 
Introduction 
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Atg9A localizes in the trans-Golgi network in nutrient-rich conditions. Atg9 has more 
homologs, for example Atg9B, which is present in placenta (Yamada et al., 2005). Atg9 
and Atg16L appear in separate populations and subsequently they fuse during the 
autophagosome formation.  
 
Mammalian cells have two kind of phosphoinositide 3-kinase that are involved in 
autophagy regulation: class I and class III. These proteins are homologous of Vps34. These 
components are part of three complexes: firstly, Ambra1 and Beclin1 regulate Atg14 
complexes; secondly, the UVRAG complex has a protein called UVRAG, which participes 
in endocytosis and autophagy; thirdly, the KIAA0226/Rubicon complex, which regulates 
negatively autophagy (Feng et al., 2014).  
 
The formation and elongation of the autophagosome is regulated by Atg9. Additionally, 
two highly complexes are involved in this step. These multiprotein complexes are called 
conjugation systems. Both complexes are ubiquitin-like conjugation systems, and are 
formed by Atg5-Atg12 and Atg8/LC3/GABARAP-phosphatidylethanolamine (PE) 
(Mizushima et al., 2003). Atg7 directly activates and transfers Atg12 to Atg5. Atg5 present 
two UBL domains, but when the Atg5-Atg12 conjugated is formed, three UBL domains 
are activated. These three UBL domains recruit the factors needed for the elongation of the 
autophagosome. Additionally, Atg16L1 is implicated in this complex, ensuring the 
association between the complex and the pre-autophagosome structure (PAS). The aim of 
this complex is to give E3-like activity to Atg8 (LC3 in mammals), to induce the 
connection with PE (Kabeya et al., 2000).  
 
Atg8 is synthetized as a cytosolic protein, and it is processed by Atg4. After that, Atg8 is 
activated by Atg7 and transferred to Atg3 to be linked to the PE. In humans, there are six 
homologs of Atg8: LC3A, LC3B, LC3C, GABARAP, GABARAPL1 and GABARAPL2. 
The LC3s are encoded by four genes: MAP1LC3A, MP1LC3B, MAP1LC3B2 and 
MAP1LC3C (Wild et al., 2014). The LC3B is the most studied Atg8 protein to date. This 
protein is attached to the autophagosomal membrane during their formation and 
maturation. While LC3B is in the cytosol, it is called LC3-I, nevertheless, as soon as LC3B 
is lipidated and attached to the membrane, it is called LC3-II.  
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The final step in autophagy is the autophagosome fusion with lysosomes. Previous results 
demonstrated that the SNARE protein family has a major role in the fusion of the 
membranes (Wang et al., 2016). Interestingly, Atg8 could be implicate in the fission of the 
autophagosomal and lysosomal membrane by tethering (Nguyen et al., 2016). The lumen 
of the autophagosome is degraded by lysosomal enzymes. The resultant molecules are 
transported from the lysosome to the cytosol through permeases for the last step of 
recycling. This step is crucial to transform autophagy, not only in a cleaning mechanism, 
but providing novel pathways to get energy.  
 
Importantly, LC3B is attached to the autophagosomal membrane, and the lysosomal 
proteases degrade LC3-II. The part attached to the external membrane come back to the 
cytosol, after Atg4 break the connection with PE (Tanida et al., 2004). LC3B is the unique 
marker for autophagosomes to date. In fact, the relative quantity of LC3-II sights the 
autophagosomal amount. (Mizushima, 2004). But, due to the dynamism of the 
autophagosomes, autophagic flux is necessary to be determined (Mizushima and 
Yoshimori, 2007).  
 
1.1.1.2 Selective autophagy 
 
The selective autophagy of organelles is crucial to maintain cellular homeostasis (Anding 
et Baehrecke, 2017). The selective autophagy implies the specific recognition of the cargo 
to be degraded by specific receptors. All of them present an initial signaling that induces 
events, molecules that tag the cargo to be degraded and the elimination of the cargo 
through autophagy. The organelles described to have specific degradation are 
mitochondrias, peroxisomes, lysosomes, endoplasmic reticulum, nucleus, protein 
aggregates, proteasomes, lipid droplets and polyribosomes (Reggiori et al., 2012). In 
addition intracellular bacteria are also degraded via selective autophagy. 
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Figure 1.3. Selective autophagy. Autophagy can degrade specifically cellular compounds to determine 
cellular development or to clean specific material from the cytosol. From Galluzi et al., 2017. 
 
Mitophagy, or the specific degradation of mitochondria was firstly observed by de Duve 
(De Duve and Wattiaux, 1966), and then described in 2005 (Lemasters, 2005). 
Mitochondria can be depolarized by several stimuli, such as hypoxia, chemical uncouplers 
of oxidative phosphorilation or ROS. It has been demonstrated that this process is quite 
important for several circumstances, such as during development to change the metabolic 
profile (Esteban-Martinez et al., 2017). There are several proteins implicated in mitophagy, 
but the best-known mitophagy-related proteins are Pink1 and Parkin. These proteins act as 
receptors during mitophagy and are linked to Parkinson disease (Lazarou et al., 2015; 
Eiyama et al., 2015). When mitochondrial membrane potential is compromised, 
ubiquitinated Pink1 accumulates in the mitochondrial surface and Parkin amplifies the 
signal of Pink1. This high-ubiquitnated signal can be recognized by autophagy receptors 
and take the mitochondria to autophagosomes (Lazarou et al., 2015). Further experiments 
are demonstrating that these are not the only receptors for mitophagy. For example, 
Mitofusin-1 and Mitofusin-2 are proteins implicated in the fusion and fission of 
mitochondrial, but Mitofusin-2 serves as a receptor for Parkin translocation to damaged 
mitochondria (Gegg et al., 2010). 
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Lysophagy is the specific degradation of lysosomes, recently defined by Hung and 
colleagues (Hung et al, 2013). Lysosomes are the stomach of the cells, and some damage 
in the lysosomes can promote cellular distability, leading to cell death (Hasewaga et al., 
2013). Lysophagy can be induced by several stimuli, such as silica crystals or 
photodamage (Hung et al., 2013). Lysophagy still presents several questions to be solved, 
but the methods to monitor this mechanism are being defined. For example, light damage 
allows studying the exact place of the damaged lysosomes, giving the opportunity to study 
lysophagy (Chu et al., 2017; Otomo et Yoshimori, 2017). Additionally, it has been 
demonstrated that, after lysosomal damage, LC3 and galectin-3 are recruited to the 
lysosome. Interestingly, galectin-3 colocalizes in damage membrane with p62 in mouse 
embryonic fibroblasts (Chauhan et al., 2016). Moreover, ubiquitination of damage 
lysosomes is involved in damage recognition and recruitment of autophagic machinery 
(Yoshida et al., 2017). Nevertheless, lysophagy still has many questions to be solved, for 
example, which are the mechanisms able to induce the ubiquitination of damaged 
lysosomes, or what is the signal received by galectin-3 to bind to damaged membranes.  
 
Pexophagy, is the specific degradation of peroxisomes, small organelles implicated in the 
catabolism of fatty acids and the reduction of ROS. Due to the role of removing oxidative 
stress, peroxisomes are essential for the cellular homeostasis. In some situations, 
peroxisome-specific degradation is activated, for example after the treatment with 
hypolipidemic drugs (Till et al., 2012) or in amino acid starvation (Sargent et al., 2016).  
 
Additionally, ER-phagy or reticulophagy is the specific degradation of endoplasmic 
reticulum (Bernales et al., 2006). ER-phagy is activated after the unfolded protein response 
(UPR) and ER-associated degradation (ERAD) (Wang and Kaufman, 2016).  
 
Nucleophagy; because nucleus contains genetic material of the cells, degradation could be 
detrimental for the cells; but nucleophagy involves only a partial fragment of nuclear 
components. This includes portions of the nuclear envelope with pre-ribosomes, but 
excludes chromosomal DNA or nuclear pore complexes (Farré et al., 2009). 
 
All of these mechanisms lead to show how delicate autophagy is. Slight control of 
autophagy lead to the cell not only to obtain energy through bulk-degradation, but specific 
organelles degradation to get different objectives: survival, metabolism profile change or 
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overpass stress damage. To discover the molecular mechanisms will be relevant for future 
researches. 
 
1.1.1.3 Autophagy-independent functions of Atg proteins 
 
Autophagy proteins present roles in other processes in the cell. The novel autophagy-
independent roles are being studied. The research about this is complicated due to the 
different role of autophagy in the tissues.  Beclin1, as defined previously, participates in 
the induction of autophagy. Beclin1 is present in the Vps34 complex I and II. In 2011, by 
using an autophagy inhibitor called spautin-1, Liu and colleagues demonstrated that 
Beclin1 expression regulates the levels of p53 by increasing the ubiquitination (Liu et al., 
2011).   P53 is called the “guardian of the genome” due to his role to prevent tumor and 
take care of the genome stability. P53 is mutated in 50% of human tumors (Vousden and 
Prives, 2009). If Beclin1 is able to control the levels of p53, this indicates that Beclin1 has 
an important role in oncogenic control. However, p53 is also able to control autophagy 
(Tasdemir et al., 2008). 
 
Other example is FIP200 (FAK family-interacting protein of 200 kDa); FIP200 is a protein 
equivalent of the yeast gene Atg17. FIP200 is participating in the complex 
ULK1/Atg13/Atg101 for autophagy induction (Hara et al., 2008). In 2016, FIP200 knock-
in mutant allele was generated, leading to the study of FIP200 role in embryogenesis, cell 
survival and tumor growth (Chen et al., 2016). They used a mutant of FIP200 called 
FIP200-4A. FIP200-4A presented a mutation in the region where the protein interacts with 
Atg13. The protein FIP200-4A blocked autophagy in mouse embryonic fibroblasts, but, 
although FIP200 knock-out mice were lethal during embryogenesis, FIP200-4A leaded the 
complete embryogenesis in mouse, suggesting that FIP200 presented an autophagy-
independent role and related to embryogenesis. Additionally, FIP200-/- phenotype during 
development is very similar to other Atg deficient knock-out mouse models. 
 
Other examples are the ubiquitin-like Atg8 family of proteins. Atg8 is the yeast protein 
and it presents 6 orthologues in humans, as commented previously. Interestingly, these 
proteins interact with 67 other proteins, including GTPases (Wang et al., 2012). The 
GTPases are proteins with multiple roles in the cell, such as cycle progression, gene 
expression, migration or signaling. For example, non-lipidated LC3 is a regulator for viral 
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replication; Coronaviruses and mouse hepatitis virus are RNA viruses that induce 
accumulation of endoplasmic chaperones in double membrane vacuole coated by non-
lipidated LC3: the down-regulation of LC3 –but not of autophagy- inhibited coronavirus 
infection.  
 
Additionally, other non-ubiquitin-like Atg proteins present autophagy-independent roles. 
For example, Atg16L present a crucial role for hormone secretion of PC12 cells. Knock-
down of Atg16L causes a reduction in the secretion, independently of autophagic activity 
(Ishibashi et al., 2012).  
 
Other examples are the proteins Atg5 and Atg7. During the attachment to the bone, 
osteoclasts become polarized. For this mission, lysosomal enzymes such as cathepsin K 
need to be secreted to the resorptive space. Atg5 and Atg7 are needed for the localization 
of secretory lysosomes during the polarization of the osteoclasts (DeSelm et al., 2011). 
Additionally, Atg7 has been implicated in more roles; for example, a recent study 
demonstrated that autophagy and cell cycle arrest are synchronized during starvation. In 
starved MEFs, Atg7 is essential for the interaction with p53 and for the transcriptional 
activation of the cell cycle inhibitor p21CDKN1A. These results indicate that Atg7 is also 
implicated in cell cycle arrest (Lee et al., 2012). Furthermore, Atg5 and Atg7 are 
implicated in adipogenesis in mice. Adipose tissue is smaller than compared to the wild-
type in animals knock-out for these proteins. It is evident that Atg5 and Atg7 present a role 
autophagy-independent due to the inhibition of autophagy leads to an accumulation of the 
lipid droplets (Baerga et al., 2009; Zhang et al., 2009).  
 
In addition, in germ-specific knock-out for Atg7 mice, it was observed that the animals 
were sterile. Acrosome is a lysosome-related organelle that plays an important role during 
fertilization in the sperm nucleus. The authors observed that germ-specific Atg7 knock-out 
presented a deficiency during the formation of the acrosome, leading to the infertility. 
Interestingly, Atg7 regulates another protein called Golgi-associated PEDZ and coiled-coil 
motif-containing protein (GOPC), proteins implicated in acrosome formation. This 
publication suggests that Atg7 is regulating, through other proteins, the acrosome 
formation (Wang et al., 2014). 
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It is important to understand that autophagy is implicated at several levels in the cellular 
processes, but further non-autophagy roles of the Atg machinery are being unraveled. 
Moreover, the knock-out mice of the Atg proteins demonstrate different phenotypes, from 
embryogenesis to tumors in adulthood. Definitely, autophagy, cell death and cell 
proliferation are processes quite related, with similar molecular mechanisms. 
 
1.1.2 Autophagy and neurodegeneration  
 
Intracellular aggregates are common in neurodegenerative diseases. Mutations in proteins 
contribute to diseases, such as α-synuclein in Parkinson’s disease; expanded 
polyglutamine zones in Huntingtin in Huntington’s Disease. The importance of autophagy 
has been previously described. For example, knock-out mice for Atg7 and Atg5 present 
neurodegenerative phenotype, suggesting the importance of autophagy-related proteins in 
pathologies (Hara et al., 2006). Autophagy is a regulator of the levels of protein 
aggregates, such as polyglutamine huntingtin in Huntington’s Disease (Ravicumar et al., 
2002); mutant α-synuclein in Parkinson’s Disease (Webb et al., 2003); mutant TDP-43 in 
ALS 7 and tau proteins in some dementias (Berger et al., 2008). In addition, Parkinson’s 
disease presents deficiency in Pink1 and Parkin genes, suggesting the meaning of 
mitophagy in this illness. Additionally, to their role in mitophagy, Parkin1 has been 
described to be involved in the degradation of α-synuclein (Lonskaya et al., 2013). 
  
Alzheimer Disease is characterized by the accumulation of amyloid-β plaques. 
Interestingly, accumulation of autophagosomes was observed in affected neurons (Nixon et 
al., 2005). Some experiments have demonstrated problems in lysosomal function due to the 
mutations in the presinilin family. These mutations result in autophasosome accumulation. 
Further, deletion of cystatin B (an inhibitor of lysosomal proteases) in an Alzheimer 
Disease mouse model improved mouse cognitive performance (Yang et al., 2011). 
Moreover, Beclin1 presents reduced levels of mRNA in Alzheimer Disease brain, 
suggesting the importance of autophagy in this disease (Pickford et al., 2008). 
 
In Huntington Disease, it has been described autophagosomes accumulation in biopsies of 
patients. Additionally, several autophagy markers such as p62 or LC3 appear increased. 
Interestingly, autophagosomes were not degraded. Interestingly, targeting autophagy 
induction could be a new therapy for the treatment of this disease. For example, the 
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rapamycin analog CCI-779 induced autophagy-dependent degradation of the accumulated 
huntingtin aggregates and improved motor phenotype in transgenic mice (Ravicumar et al., 
2002). Moreover, trehalose, a disaccharide that induces autophagy, also improved motor 
function and extended lifespan in transgenic mice (Tanaka et al., 2004) 
 
These publications demonstrate that autophagy could be a therapeutic target to induce 
during neurodegenerative diseases which present aggregates accumulation as origin of the 
disease. Additionally, it is important to look for therapies that avoid the phenotype of the 
disease from the origin and prevent the accumulation of the proteins. This thesis is focused 
in retinal neurodegeneration diseases, but these groups of diseases will be explained later 
in the introduction.  
 
1.1.3. Autophagy in cancer  
 
The role of autophagy in normal cells presents high complexity and it is tissue-dependent. 
For example, autophagy is essential in brain, muscle and liver due to the necessary removal 
of damaged organelle. Otherwise, autophagy presents a intricate role in cancer, as a tumor 
suppressor or tumor-helper. Autophagy can be a tumor suppressor, for example the gene 
Beclin1 is monoallelic in 40-75% of human breast, prostate and ovarian cancer (Aita et al., 
1999; Liang et al., 1999). Additionally, deficiency in Atg5 or Atg7 can induce liver tumors 
in mice (Takamura et al., 2011). These results indicate that autophagy acts as a tumor 
suppressor.  
 
On the other hand, autophagy can be a tumor promoter. Autophagy is increased in hypoxic 
tumor regions (essential for tumor cell survival) (Degenhardt et al., 2006), and it is also 
increased in RAS-transformed cells (Guo et al., 2011). The genetic context that promotes 
autophagy as a tumor promoter is poorly understood. Autophagy helps in the growth and 
progression of tumors due to the ability of reducing the environmental stimuli. Several 
advanced tumors exhibit an increase autophagic flux (Mikhaylova et al., 2012). These 
experiments support the idea that autophagy is helping during tumorigenesis and tumor 
development. 
 
It will be necessary to understand which are the circumstances that promote that autophagy 
induces tumor cell death, or tumor development. Genetic context, type of tumor, or 
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deficiency of autophagy-related proteins could affect to the unbalance of the different roles 
of autophagy. 
 
 
1.2 LYSOSOMES 
 
Lysosomes are acidic organelles discovered by Christian de Duve in 1950´s (De Duve and 
Wattiaux, 1966). Lysosomes are membrane-bound organelles with acidic lumen. 
Lysosomes are ubiquitous and they present more than 60 hydrolytic enzymes and other 
transmembrane proteins implicated in the maintenance of the acidic gradient, as ATPases 
that pump protons to the lysosomal lumen and other proteins in charge of the molecular 
export through the lysosomal membrane.  
 
Lysosomes are implicated in multiple mechanisms: degradation of external compounds 
through phagocytosis; degradation of internal compounds through endocytosis or 
autophagy – and this include the three types of autophagy: macroautophagy, chaperone-
mediated autophagy and microautophagy. The molecules obtained are transported to the 
cytosol via transport channels or release to the extracellular space via exocytosis. 
Additionally, lysosomes have an important role as calcium storages (Churchill et al., 
2002).  
 
Lysosomal biogenesis is regulated by the transcription factor EB (TFEB) due to his ability 
to promote expression of most of the lysosomal proteins. This transcription factor binds to 
the coordinated lysosomal expression and regulation (CLEAR) promoter (Sardiello et al., 
2009). Additionally, to the biosynthetic pathway, endocytic pathway is implicated in 
lysosomal biogenesis: early endosomes are completed with hydrolases until the complete 
maturation.  It is important to understand how lysosomal biogenesis works due to the 
possible therapeutic functions it can present; for example, it has been demonstrated that an 
increase in the lysosomal amount can improve several protein aggregate-related diseases, 
such as Parkinson or Alzheimer (Napolitano and Ballabio, 2016). Until now, it has been 
described that TFEB is regulated by mTOR complex 1. In normal situations, mTOR 
phosphorylates TFEB and recruits it in the cytoplasm. As commented previously, mTOR is 
inactivated during starvation, leading to TFEB to be dephosphorylated and translating to 
the nucleus, where promotes the transcription of the CLEAR gene network (Settembre et 
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al., 2013). Recent studies have demonstrated that TFEB can be activated independently of 
mTOR. The serine/threonine kinase Akt (protein kinase B) controls TFEB activity after 
trehalose treatment, an mTOR-independent autophagy inducer. Akt phosphorylated TFEB 
at Ser647 and represses TFEB nuclear translocation. Trehalose administration reduces the 
phenotype in a mouse model of neurodegenerative disease that shows intralysosomal 
accumulation (Palmieri et al., 2017). Although lysosomes biogenesis is poorly understood, 
other protein implicated in this mechanism has been recently found. In Drosophila model 
of eye degeneration of tauopathy or amyotrophic lateral sclerosis diseases, Mask, an 
Ankyrin-repeat and KH-domain containing protein, is able to boost the ATPase activity in 
a TFEB-independent manner (Zhu et al., 2017). Futher studies are needed to understand 
the mechanisms of lysosomal biogenesis. 
 
As expected, lysosomal hydrolytic enzymes are essential to preserve lysosomal function. 
Lysosomal hydrolases digest macromolecules in an acidic environment (lysosomal lumen 
pH is about 4,5-5), but some of them are also active at higher pH, such as cathepsin B, D, 
L. This is the reason why lysosomal leakage is a scene that can induce cell death, as when 
enzymes leak to the cytosol; they are able to degrade cytoplasmic proteins. This process of 
leakage is called lysosomal membrane permeabilization (LMP), a multi-pathway process 
that in most of the cases induce cell death.  
 
 
1.2.1 Lysosomal membrane permeabilization 
 
Lysosomal membrane permeabiliation (LMP) is a perturbation of the lysosomal 
membrane that induces the release of the lysosomal enzymes to the cytosol. Interestingly, 
lysosomes do not change their morphology during LMP (Brunk and Ericsson, 1972). This 
fact has resulted in reduced interest in this mechanism until new methods to assess LMP 
have been developed. In addition, LMP has been recently studied due to the fact that 
cathepsins are able to trigger cell death through conserved executors of cell death, such as 
caspases. 
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Lysosomes can be damaged under many different scenarios (figure 1.4). For example, 
lysosomes can be damaged by free radicals. Oxidative stress induces damage in the lipids 
of the lysosomal membrane or impairment in the lysosomal enzymes. Moreover, an 
increase in H2O2 levels reacts with the redox-active iron in Fenton-type reactions, inducing 
the production of the highly reactive hydroxyl radicals (Kurz et al., 2008a). This process 
can be blocked by using desferoxamine acting as an iron chelator (Krenn et al., 2015). 
Additionally, antioxidants have been demonstrated to protect against oxidative stress 
induced LMP (Kurz et al., 2008b). 
 
Lysosomotropic agents form a group of weak bases compounds that accumulate inside 
lysosomes due to their detergent-like properties. These compounds are able to damage 
lyosomal membranes. Some examples of lysosomotropic agents are ciprofloxacin (Boya et 
al., 2003), sphingosine (Kågedal et al., 2001) or siramesine (Ostenfeld et al., 2008). Some 
of these lysosomotropic agents have been proposed as anticancer treatment, such as 
siramesine (Ostenfeld et al., 2005). The lysosomotropic agents are usually trapped in 
lysosomes, such as silica crystals or nanoparticles, used as LMP inductors. Additionally, 
some detergents, such as Leu-Leu-OMe (LLOMe), act as lysosomotropic agents. LLOMe 
has been proposed as an apoptotic inducer compound but his activity depends on the levels 
of cathepsin C to promote lysosomal damage (Thiele and Lipsky, 1985). Recently, new 
data support that sub-apoptotic concentration of LLOMe induces LMP in the lysosomes in 
Hela cell line due to the loss of proton gradient and release to the cytosol of lysosomal 
markers, but there was no evidence of release of cathepsin B and L into the cyotosol 
(Repnik et al., 2017). The authors proposed that LLOMe do not induce cathepsin release 
but induce lysosomal-dependent cell death through proteolysis signaling.  
 
As mentioned above, released cathepsins can trigger the degradation of cytoplasmic 
proteins. Additionally, some cytoplasmic proteins are able to induce LMP. For example, 
the group of Torriglia demonstrated that calpain1 causes LMP by cleavage of Lamp2 in rat 
brains. Lamp2 degradation was rescued by using calpain inhibition or MEFs Lamp2 -/-. 
These data suggested that calcium-activated calpain1 was inducing Lamp2 cleavage 
(Villalpando-Rodriguez and Torriglia, 2013).  
 
Another important fact for lysosomal stability is the membrane lipidic profile. Researchers 
have used a model system of Parkinson’s disease called BE (2)-M17 neuroblastoma cells 
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treated with the neurotoxin 1-methyl-4-phenylpyridinium (MPP+). They observed that 
MPP+ induced cholesterol accumulation in pre-apoptotic cells. When they treated the cells 
with U18666A, an intracellular cholesterol transport inhibitor, they observed a reduction in 
lysosomal damage and cell death. This suggests that increased lysosomal cholesterol is 
inducing a release of the lysosomal content to the cytosol (Eriksson et al., 2017). 
Additionally, our group observed that Parkinson’s Disease displayed LMP in neuronal 
cells. Interestingly, enhacement of lysosomal biogenesis improved the phenotype in the 
cells (Dehay et al., 2010). 
 
Additionally, several proteins are able to stabilize lysosomal membranes. For example, it 
has been demonstrated that Hsp70 interacts with BMP and induces a decrease in the acid 
sphingomyelinase (ASM) (Perdersen et al., 2010). Hsp70 deletion induces LMP and 
cathepsin release, leading to cell death (Nylandsted et al., 2014). This enzyme is in charge 
of transforming ceramide to sphingomyelin. This data is quite important because it has 
been demonstrated that an increase in sphingomyelin species implies lysosomal destability 
(Petersen et al., 2013).  
 
LMP has not only been observed in vitro but also in vivo, during physiological conditions. 
For example, during the regression of the mammary gland after lactation, LMP-mediated 
cell death is activated. During the involution, lysosomes of the mammary gland undergo 
LMP through Stat3, which upregulates caspases 3, 6 and 7 (Kreuzaler et al., 2011). In 
addition, other authors studied the role of calpains during the mammary gland involution. 
They demonstrated that calpains are able to proteolyze subunit b2 of the v-type H+ ATPase 
and Lamp2, demonstrating that the calpain-induce cleavage in Lamp2 is a process that can 
happen in mammary gland tissue (Arnandis et al., 2012).  
 
Neutrophile cell death presents LMP during infection and inflammation after Escherichia 
coli infection (Loison et al., 2014). In this case, neutrophils present the release of the serine 
protease PR3, leading to cleaved caspase 3 and cell death. The use of DFO rescues from 
the neutrophil cell death. Additionally, in macrophages infected by Legionella 
pneumophila, a bacterial protein called RpsL induces LMP in the macrophage to induce a 
productive infection (Zhu et al., 2015). Interestingly, when macrophages are infected by 
pneumococci, they induce suicide through cathepsin D release (Bewley et al., 2011). These 
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results demonstrate the importance of the LMP due to the ability of be a homeostatic 
response that occurs in vivo. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4. Inducers of lysosomal membrane permeabilization. Reactive oxygen species can pass through 
the lysosomal membrane; free iron can induce the Fenton reaction; lysosomotropic detergents and some 
antibiotics can destabilize lysosomal membrane. All of these circumstances induce LMP. Additionally, 
photodamage or activated calpains target several lysosomal proteins, such as Lamp2 and Hsp70. From 
Serrano-Puebla and Boya, 2015. 
  
LMP induces a cell death defined by the Nomenclature Committee on Cell Death as 
lysosome-depedent cell death (LDCD) (Galluzi et al., 2018). This type of cell death will 
be commented in the appart 1.3.3. Understanding deeply the mechanisms that promote 
LMP is indispensable to avoid lysosome-dependent cell death or induce these mechanisms 
to trigger cancer cell death. 
 
 
1.2.2 Lysosomes and neurodegeneration 
 
LMP has been observed in several models of neurodegenerative diseases. First, this 
condition was observed in models of stroke. In 1996, Yamashima and colleagues described 
the first evidence of a pathway that implicates a calcium-calpain dependent lysosomal 
damage (Yamashima et al., 1996). They demonstrated that the mechanism of 
postischaemic hippocampus neuronal death, there is an increase in the intracellular calcium 
levels, leading to calpain activation that induced lysosomal destabilization. Later, in 2012, 
it was demonstrated that the molecular target of calpain in this model is the protein Hsp70, 
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leading to cell death associated to a necrosis-like phenotype (Zhu et al., 2012). 
Interestingly, the motor cortex is protected against ischemia neuronal cell death, suggesting 
that this kind of cell death is cellular dependent (Zhu et al., 2012).  
 
Other example of LMP-related neurodegenerative models are some models of Parkinson’s 
disease treated with the parkisnsonin toxin MPP+. Interestingly, rapamycin was able to 
attenuate the neuronal death phenotype in the mouse model (Dehay et al., 2010). Another 
publication demonstrated that mutations in presinilin-1 (PS1) found in Alzheimer Disease 
causes lysosomal disturbance through cleaving v-ATPases (Lee et al., 2010). Interestingly, 
this phenotype is ameliorated by increasing lysosomal biogenesis. Moreover, cultured 
neural stem cells presented lysosomal damage after using chloroquine (HCQ) or 
bafilomycine A1 (BafA1) treatment. Fascinatingly, in this Alzheimer Disease model, Atg7 
downregulation ameliorate this phenotype (Walls et al., 2010).  
 
In the retina, it has been demonstrated that lysosomal stability is crucial for retinal 
homeostasis. For example, in retinal detachment in rats, calpains are activated triggering 
photoreceptor cell death (Chinskey et al., 2014). They did not study lysosomal stability, 
but it will be interesting to unravel how calpain activation leads to LMP under these 
conditions. In addition, retinal degeneration has also been described in the mouse model 
knock-out for acid sphingomyelinase (ASM). ASM knock-out is a mouse model which 
presents a deficiency in the acid sphingomyelinase activity. This model is used as a 
Niemann Pick type A mouse model. This mouse model presents an attenuated response in 
ERG, thin retinal layer and lipofuscin accumulation (Wu et al., 2015). Interestingly LMP 
and cathepsin release is also observed in Niemann Pick type A, a lysosomal storage 
disorder (LSD) with mutations in the ASM gene (Gabandé-Rodriguez et al., 2014). 
 
LSD’s are a heterogeneous group of inherited diseases characterized with the lack of one 
lysosomal enzyme. This defect promotes the accumulation their substrate in the lysosomal 
lumen, such as glycoproteins, lipids, glycoaminoglycans. All the LSD’s share similar 
clinical characteristics and some of them include retinal neurodegeneration. For example, 
the accumulation of sphingolipids in the cell promotes macular degeneration (Chen et al., 
2014). For example, Niemann Pick type C present impaired retinal function by ERG 
(Claudipierre et al., 2011). Finally, the Hexb-/- and b-Gal -/- mouse model, monetizing 
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Sandhoff disease show accumulation of storage material in retinal ganglion cells (Denny et 
al., 2007). 
 
In conclusion, these evidences demonstrate that lysosomal function is essential for 
neuronal cells. Understanding the mechanisms will be crucial to find potential targets for 
new therapeutic strategies for these diseases. 
 
1.2.3 Lysosomes and cancer 
 
As lysosomes present all these degradative enzymes inside they can be exploited to kill 
cells. This advantage can be used to fight against cancer and LMP can represent be a new 
therapeutic approach in apoptosis-resistant tumors. Some compounds, like cationic 
amphiphilic drugs (CADs) are being started to be used to kill cancer cells.  
 
CADs include hundreds of pharmacologic agents used to treat a broad spectrum of 
common diseases, e.g. psychiatric disorders, allergies, heart diseases and infections 
(Kornhuber et al., 2010). They are characterized by a hydrophobic ring structure and a 
hydrophilic side chain with a cationic amine group. In acidic milieu, the basic amine 
groups are protonated allowing an up to 1000-fold drug accumulation inside acidic 
lysosomes (Trapp et al., 2008). The incorporation of CADs into membranes in the 
lysosomal lumen neutralizes the negative membrane charge thereby inhibiting the function 
of several lysosomal lipases, including ASM. The inhibition of ASM promotes the 
accumulation of sphingomyelin (Kolzer et al., 2004). Cancer cells are especially sensitive 
to the accumulation of sphingomyelin (Barcelo-Coblijn et al., 2011, Teres et al., 2012, 
Petersen et al., 2013), which may explain why CAD’s, that are effective acid 
sphingomyelinase inhibitors, display selective cytotoxicity towards transformed cells 
(Petersen et al., 2013, Sukhai et al., 2013, Jahchan et al., 2013, Shchors et al., 2015).  
 
Other compounds, such as silica crystals or nanoparticles, have been used as new therapies 
against cancer through cathepsin release and lysosome-dependent cell death (Gutierrez et 
al., 2016; Domenech et al., 2013). New windows of therapy have been launched after these 
experiments, leading to the cancer fight another option by using the powerful proteolytic 
bombs inside the cells: the lysosomes.  
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1.3 CELL DEATH 
 
Cell death is a natural process that occurs under physiological conditions and is necessary 
to change cellular profiles in tissues, to balance the mitotic process in physical limited 
tissues, such as the intestine, and to renovate tissues to improve their function. Cell death is 
defined as the point of no-return, when the cell is no longer been functional (Galluzi et al., 
2012). It could be presented in the nature as a suicide form, or as the mechanisms of killing 
other cells; for example, cell death can be found in the immune system, when the natural 
killer cells find tumor cells. Additionally, excessive cell death can be found in several 
diseases, such as in neurodegeneration. Conversely, reduced cell death can be associated to 
cancer. 
 
Historically cell death has been classified by morphological criteria. Recently, the 
recommendations of the Nomenclature Committee on Cell Death have unified the 
nomenclature depending on the morphological and molecular characteristics. The 
Nomenclature Committee on Cell Death had described these types of cell death: apoptosis 
is the most well-known process, characterized by cascade activation and chromatin 
condensation. Necrosis is characterized by the break in the plasma membrane and loss of 
the intracellular content; autophagy-dependent cell death (ADCD) is characterized by 
the massive accumulation of autophagosomes without chromatin condensation. These three 
types of cell death have been the most described, but new types of cell death are appearing 
with the researches progress. For example, mitotic catastrophe is a type of cell death 
characterized by aberrant mitosis and cell death in mitosis or in the next step of the 
interphase. It is still under debate because it is not a cell death process perse, but it is a 
consequence of an oncosuppresive pathway. Pyroptosis is another mechanism introduced 
in 2000 (Brennan et Cookson, 2000). However, pyroptosis can present apoptotic or 
necrotic characteristics.  
 
Lysosome-dependent cell death (LDCD) is another type of cell death described by the 
new nomenclature. Nowadays, lysosome-dependent cell death is described as the 
lysosomal disruption and lysosomal membrane permeabilization. This situation appears in 
several physiopathological situations, such as during mammary gland involution, aging or 
neurodegeneration. The LMP leads to lysosomal content release, but the pathways 
Introduction 
 30 
downstream have not been elucidated. Sometimes, lysosomes appear permeabilized before 
the mitochondria, leading to activate other pathways, such as apoptosis or pyroptosis.  
One feature of lysosomal-related cell death is that inhibiting LMP or blocking the 
cathepsin activity delay the cell death.  
 
1.3.1 Apoptosis 
 
Depending on where the death signals are coming apoptosis can be distinguished in two 
types. The extrinsic apoptosis describes the situation where apoptosis signals are 
extracellular signals which bind to transmembrane receptors. For example FAS/CD95 
ligand, tumor necrosis factor alfa or TNF family (Galluzi et al., 2012). The intrinsic 
apoptosis pathway is triggered by intracellular signals, such as DNA damage, oxidative 
stress, and accumulation of unfolded proteins in the endoplasmic reticulum or increase of 
cytosolic calcium. Both of these pathways converge in changes in the mitochondrial 
membrane potential. Mitochondrial membrane is permeabilized, forming a pore with the 
proapoptotic members of the BCL-2 protein and cytochrome c is released and triggers the 
formation of the apoptosome, and the activation of caspase 9 and caspase 3 (Galluzi et al., 
2012). AIF and ENDOG are proteins that appear in the nucleus, mediating the DNA 
fragmentation.  
 
1.3.2 Autophagy-dependent cell death (ADCD) 
 
The term autophagy-dependent cell death (ADCD) was described by Christian de Duve 
(De Duve et al., 1955). Although autophagy is a protective process that happens in several 
circumstances to prevent necrosis or apoptotic cell death, for example during starvation, 
ACD has been termed to describe the situations when the cells die by autophagy. This cell 
death is characterized by the accumulation of autophagosomes preceded by an increase in 
the autophagic flux. If inhibition of autophagy does not prevent cell death, this process is 
not autophagic cell death. This process has been observed during fly development. one 
example is during the regression of the salivary glands in Drosophila melanogaster 
(Baehrecke, 2003).  
 
ADCD also has been shown to occur in apoptotic-resistant cells, for example in the 
absence of Bax and Bak (Shimizu et al., 2004; Yu et al., 2004). Interestingly, these cells 
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can die with autophagic inductors, and this kind of cell death can be avoided by using 
autophagy inhibitors, or silencing autophagy-related proteins, such as Atg5 (Shimizu et al., 
2004). Importantly, autophagy is necessary, but not sufficient to induce ACD because it 
needs more death signals, like c-Jun N-terminal kinase (JNK). JNK appears increased 
when ACD is happening (Shimizu et al., 2010). Molecular participants in ACD should be 
discovered to understand the differences and specificity of this kind of cell death. 
 
1.3.3 Lysosome-dependent cell death (LDCD) 
 
LMP can induce cell death through several pathways. For example, it has been observed 
that LMP triggers apoptosis in a caspase dependent or independent manner. Additionally, 
LMP can activate inflammasome, inducing cytokines release and activating macrophages – 
process called pyropoptosis. The common condition for LMP-induced cell death is that it is 
able to prevent them by using cathepsin inhibitors. The common patterns between one 
pathway and another remain still unknown. To discover whether the origin of the induction 
of LMP is releasing one pathway or another would be interesting to understand how the 
lysosomal-induced cell death mechanism is happening. Interestingly, transformed cells 
have an increased sensitivity to LMP inducers (Pedersen et al., 2013), which have 
promoted a recent interest in the research of this field, looking for new therapeutic targets 
to kill cancer cells. 
 
LMP promotes the release of cathepsins to the cytosol. Most of the cathepsins remain 
inactive at neutral pH, except cathepsin B, D and L. These three cathepsins can trigger a 
cascade of molecular events, activating cell death. For example, cathepsins are able to 
cleave the BH3-only protein Bid or Noxa, inducing mitochondrial membrane 
permeabilization (MMP). Bid induces conformational changes in Bax and Bak, which 
trigger classical apoptosis cascade: MMP, cytochrome c release and caspase activation 
(Eno et al., 2013). Occasionally, LMP can induce cell death through a caspase-independent 
pathway. For example, LMP can trigger cell death in a caspase-independent manner after 
oxidative stress (Mannick et al., 2001) or siramesine (Česen et al., 2013). The reason could 
be that caspase present oxidative places in their catalytic sites that can be affected by 
oxidative stress. Another example is in ATP depletion circumstance, cell death presents a 
shift between caspase-dependent apoptosis to necrosis pathway. For example, N-(4-
hydroxyphenyl) retinamide, which is a vitamin, induce cell death in retinoblastoma tumor. 
Introduction 
 32 
This compound induces lactate dehydrogenase release, disruption of mitochondrial 
transmembrane potential and ATP depletion. Under these circumstances, cathepsin D is 
released from lysosomes. Interestingly, Pepstatin A rescued cell viability and reduced 
DNA fragmentation, which indicates that cathepsin D was able to fragment DNA, inducing 
another pathway of LMP-induced cell death (Venè et al., 2007).  
 
A variety of silica crystals and protein aggregates disrupt lysosomal integrity and activate 
the NRLP3 inﬂammasome, inducing cytokine release and activating 
macrophages/microglia and cell death. Atherosclerotic lesions present cholesterol crystals 
that can induce inflammatory response. When cholesterol crystals are injected in mice, 
acute inflammation and cathepsin B and cathepsin L release was observed. The cathepsin 
release leads to inflammasome activation (Duewell et al., 2010). Additionally, in 
Alzheimer’s Disease, the peptide amyloid Aβ induces inflammasome activation through 
lysosomal destabilization (Halle et al., 2008). 
 
Depending on the stimuli that induce LMP, the response can be totally different. It would 
be important to unravel which the molecular mechanisms are, and whether the molecular 
pathway depends on the LMP-inducer agent. This difference could set the release of 
cathepsins, or the differences in the proteins catalizes by the cathepsins. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5. Consequences of lysosomal membrane permeabilization. Cathepsin release after LMP induces 
different types of cell death: caspase-dependent cell death, caspase-independent, pyroptosis or autophagic 
cell death.  
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1.3.4 Pyroptosis 
 
Pyroptosis is a form of cell death characterized by the activation of caspase 1. Cells are 
able to activate caspase 1 after the formation of a multiprotein complex, the 
inflammasome. This response was observed in the inflammatory response, leading to 
cytokines and cathepsins release and cell death (Galluzzi et al., 2012). It has been 
described that some protein aggregates and some crystals are able to induce the NRLP3 
inflammasome, and this activation can be block by using cathepsin inhibitors (48). For 
example, flagellin, one component of the flagella of Gram positive and negative bacterial, 
is able to induce LMP. This LMP causes capase-11 dependent and independent responses, 
and inflammasome activation (Lage et al., 2013). But, the molecular pathways that link 
inflammasome and cathepsin release are poorly understood. Further studies are needed to 
unravel how the connection between LMP and inflammation is.  
 
 
1.4 VERTEBRATE RETINA 
 
1.4.1 Retina: structure and function  
 
Vertebrate retina is a layered and structured tissue with several cell types integrated in a 
complex organ. The function and morphology of this tissue is delicately organized to 
connect every circuit to produce a visual output. Five major neuronal cell classes constitute 
the retina: photoreceptors, horizontal cells, bipolar cells, amacrine cells and ganglion cells; 
and a non-neuronal cell type, the Müller glia. All these cells are intrinsically connected in a 
complex structure, divided in several layers depending on the higher content of nuclei or 
axons: outer nuclear layer (ONL), outer plexiform layer (OPL), inner nuclear layer (INL), 
inner plexiform layer (IPL) and ganglion cell layer (GCL). After the GCL, optic nerve will 
connect with the primary optic cortex (Jones et al., 2012) 
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Figure 1.6. Retinal structure. Retina is compouned by 5 cellular types: photoreceptors (cones and rods), 
horizontal, bipolar, amacrine and ganglion cells. These types are situated in layer: outer nuclear layer, outer 
plexiform layer, inner nuclear layer, inner plexiform layer and ganglion cell layer. Modified from Kumar, 
2001 and Morgan and Wong, 2005. 
 
There are two types of photoreceptors: cones and rods. Rods are activated under low light 
conditions. Cones are in charge of color recognition, they are less sensitive, but they act 
faster during the phototransduction. Photoreceptors are able to transform the electron 
energy from the light to synaptic information. Synaptic transmission between 
photoreceptors and bipolar cells is modulated by horizontal cells. Additionally, bipolar 
cells can be divided in two types: those that depolarize (ON) and those that hyperpolarize 
(OFF) to increments the light signal. The ganglion cells project their axons to the visual 
center in the brain. The ganglion cells connect with bipolar and amacrine cells in the INL. 
Excitation of amacrine cells regulates the ganglion signaling thought the contact with the 
ganglion axons (Jones et al., 2012; Vuong and Hedges, 2017).  
 
1.4.2 Photoreceptor Cell Death 
 
Photoreceptors are cells under constant stress due to their high metabolic activity in the 
presence of light. The current theory is that apoptosis is the most common cell death during 
retinal development (Young et al., 1984), while other types of programmed cell death have 
been described in retinal pathological processes. In photoreceptor for example, 
pharmacological inhibition or genetic manipulation of caspase cascade, typical apoptosic 
executors, does not avoid cell death (Yoshizawa et al., 2002). It has been described that the 
type of cell death in retinal degeneration depends on the energy availability. For example, 
if there is an ATP depletion, necrosis can be activated (Lui et al., 2004). In addition, light-
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induced photoreceptor damage activates apoptotic mechanism (Chang et al., 1993). But the 
events ocurring in inherited retinal degenerations present alternative features different from 
apoptosis.  
 
Interestingly, it has been observed that in most instances, retinal neurodegeneration is 
caused by rod degeneration. However, cones will die after rod degeneration.  This 
phenomenon is called secondary cell death,  and it has been observed for example, when 
rods present a mutation that induce photoreceptor cell death. This phenomenon could be 
explained by the loss of structural support (Sahel et al., 2001), or by the loss of trophic 
support, as for example, the rod viability factor (Mohand-Said et al., 1998). Additionally, 
dying rods may release toxic compounds to the envionviment.  
 
Several cascades have been characterized during photoreceptor cell death. First, cyclic 
nucleotide signaling. The cyclic nucleotides can be adenosine monophosphate (cAMP) 
and cyclic guanosine monophosphate (cGMP). These both molecules regulates 
intracellular signaling. For example, it has been demonstrated that cGMP can induce cell 
death (Ficuss, 2002). Several mutations in mouse models involve cGMP metabolism, 
leading to retinal degeneration. For instance, mutations affecting the cGMP-hydrolyzing 
PDE6 have been found in 10% of human retinitis cases. cAMP appears to be essential for 
cellular survival. cAMP mediates the activation of protein kinase A, which phosphorilates 
cAMP response element binding protein (CREB), a transcription factor for neuronal 
survival (Mantamadiotis et al., 2002). Inherited retinal pathologies present huge changes in 
gene transcription, involving this gene expression to cell survival or cell death.  
 
Calcium influx. Excessive calcium influx has been described as a one of the principal 
factor in photoreceptor degeneration. Calcium activates several proteins such as calpains in 
rd1 photoreceptors (Paquet-Durand et al., 2006) and rd10 (Arroba et al., 2011). On the 
other hand, calcium causes ATP depletion by activating calcium extrusion mechanisms, 
like ATPases required to take sodium outside (Gerini et al., 2005). Additionally, calcium 
influx can promote ER stress. ER stress is higly connected to cell death. In summary, 
intracellular calcium increase can lead to several situations, such as energetic colpase or 
activation of calcium-related proteins.  
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Calpain activation. Calpains are proteins with 14 isoforms and they are implicated in cell 
death. These proteins can be blocked by the specfic inhibitor calpastatin. Inhibition of 
calpastatin with calcium leads to its autocleavage, leading the calpains activation. In retina, 
pharmacological inhibition of calpains can block cell death (Araújo et al., 2004). In fact, 
calpains function is still poorly understood due to the large number of potencial substrates. 
One of that substrate is arrestin, a component of the phototransduction cascade, which 
block the interaction between rhodopsin and transducin (Azarian et al., 1995). 
Additionally, increased cathepsin activity has been showed in the rd1 (Ahuja et al., 2008). 
More factors affect to the photoreceptor cell death, such as oxidative stress, PARP 
activity or DNA fragmentation.  
 
The photoreceptror cell death is well described in the rd1 mouse model. In this case, rd1 
mouse model does not present any apoptotic-signal marker, such as cytochrome c release, 
cleavage of Bcl-2 and activation of proteins such as p53 or caspases (Doonan et al., 2003). 
PDE6 inhibition induced rod and cone cell death. The use of calcium channels blockers 
prevent retinal degeneration (Frasson et al., 1999). Sancho-Pelluz and colleguaes proposed 
a model for the photoreceptor cell death of the rd1 mouse model (Sancho-Pelluz et al., 
2008). Deregulation of cGMP levels induced by the mutation in PDE6 gene is the begining 
of the neurodegeneration. High levels of cGMP leads to the activation of cGMP channels. 
This triggers a calcium-dependent processes. High intracellular calcium levels activate AC, 
leading to the production of cAMP 116. Additionallyt, cAMP activates PKA, which can 
activate CREB. But, paradoxically, CREB appears downregulated in this model, so it is 
supossed to be a negative feedback mechanism. Downregulation of CREB reduces the 
transcription of CREB target genes, such as calpastatin. Decrease in calpastatin levels leads 
to the calcium-mediated activation of calpains. Calpains have a large number of possible 
targets, such as PARP or cathepsins, which appear increase in rd1 model. In conclusion, 
photoreceptor cell death presents different features to other cell death types. 
 
1.4.3 Autophagy in Photoreceptors  
 
Autophagy, as mentioned before, is a fundamental process that it has a relevant importance 
in the nervous system. Our lab has been studying the role of autophagy in the retina for 
several years our data and other laboratories data have demonstrated the essential role of 
autophagy to support retinal homeostasis (Boya et al., 2016). A pioneer experiment 
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demonstrated that squirrels presented less mitochondria and different cone morphology 
during hibertnation due to autophagy activation in photoreceptors (Reme and Young, 
1977). After this research, several experiments demonstrated the importance of autophagy 
in the retina, such us the demonstration that autophagosomes were present in dying 
ganglion cell during retinal development (Hornung et al., 1989).  
 
One way to study the importance of autophagy in the retina is to study retinal function and 
development in autophagy-deficient animal models. The ﬁrst mouse with a photoreceptor-
speciﬁc deﬁciency was generated by crossing ATG7ﬂox/ﬂox mice with rod-speciﬁc 
LMOP-Cre mice (Chen et al., 2013). The animals did not present alterations in the retinal 
under normal light conditions. However, these animals presented severe neurodegeneration 
after 2h of intense illumination (Chen et al., 2013). Other example studied is the Atg5 
deficiency. Mice with Atg5flox/flox were crossed with rhodopsin-iCre-75. These animals 
Atg5ΔRod presented a massive loss of photoreceptors in 20 weeks, which suggest that Atg5 
is essential for photoreceptors viability (Zhou et al., 2015a).  
 
Several autophagy-deficient mouse models die after birth, such as the knock-out mice of 
Atg3, Atg5, Atg7 or Atg9 (Ichimura et Komatsu, 2011), which difficult the study of the 
visual function; in fact, other models die during the development, such as Beclin1 knock-
out mouse model or Ambra1gt/gt. However, Atg4B knock-out mice, which present a 
normal lifespan, do not present any histological alteration in the eye under basal conditions 
(Mariño et al., 2010;) but they are more sensitive to optic nerve axotomy (Rodriguez-
Muela et al., 2012). Other animal models have been used to study eye development and 
function. For example, Ambra1 knock-out in zebrafish present smaller eyes (Benato et al., 
2013);  
 
In addition, a recent report shows an important variation in the LC3 levels depending on 
the hour of the day in mice, being the highest peak of LC3 several hours after the light 
activation, and an important decrease at the first moment of darkness (Yao et al., 2014). 
More researchers showed the relation between retina and circadian cycle. For example, it 
has been demonstrated that age-related ocular diseases, a group of diseases that include 
glaucoma, diabetic retinopathy, age-related macular degeneration, cataract and diabetic 
retinopathy can be ameliorated with melatonin, the hormone generated during the sleep 
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time (Crooke et al., 2017).  One possible explanation is that melatonin is affecting to 
sirtuins, proteins related with autophagy. 
 
1.4.4 Autophagy in other retinal diseases and aging 
 
As has been shown previously, autophagy is essential in retinal development and function. 
This implicates that autophagy must be active to avoid retinal diseases. In glaucoma, 
benefits of autophagy have been evidenced. Glaucoma is a group of molecular diseases 
characterized by the default of the optic nerve function. However, after axonal damage, a 
well described model of glaucoma and other diseases, autophagy is highly induced in the 
retina to avoid ganglionar cell death; nevertheless, animals Atg4B and Atg5 flox/flox 
presented an increase in cell death in  ganglion cells (Rodriguez-Muela et Boya, 2012).  
 
Another example of the importance of autophagy in the retina is the light-induced 
damage. To expose retina to light damage can damage the retina irreversibly. Autophagy 
induction was observed in illuminated retinas, more specifically, in photoreceptors and in 
retinal pigmentary epitelium (RPE) (Remé et al., 1999). Interestingly, the lack of some 
autophagy-related proteins induces an increase in the susceptibility in the retinal 
degeneration. As commented previously, when animals with rod-specific Atg7-deficiency 
(Atg7 flox/flox;LMOP-Cre) were exposed to light at 5000 Lux for 2 h, the mouse model 
Atg7 flox/flox;LMOP-Cre showed photoreceptor degeneration with thiner ONL and 
disrupted photoreceptor structure (Chen et al., 2013). In the same way, Beclin1-deficiency 
is increasing the susceptibility after light-induced damage (Chen et al., 2013). 
Interestingly, Atg5-deficiency was studied by using a model of rod-specific Atg5-
deficiency, called Atg5flox/flox;iCre75. Exposing the mice, there was observed that Atg5-
lack affected to the retina, but not only after light exposition. Additionally, the lack of Atg5 
in the RPE induced a diminished photoreceptor response (Zhou et al., 2015b). These 
results after light damage and axotomy suggest a role of autophagy to survive to retinal 
damage. 
 
Age related macular degeneration (AMD) is a complex group of disease characterized 
by the affection to the macula, the central region of the retina. In this case, the RPE is the 
one which degenerated during AMD. The RPE is found outside the photoreceptors and this 
group of cells is in charge of degrading the photoreceptor outside segments (POS) from the 
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photoreceptors. Autophagy is acting during the degradation of POS. Several experiments 
have demonstrated that blocking autophagy with 3-MA was increasing the levels of 
lipofuscin when RPE cells were fed with POS; additionally, autophagy stimulation with 
rapamycin treatment was inducing viability increase in RPE cells and a reduction of 
lipofuscin (Mitter et al., 2014). Molecular models have demonstrated that the balance 
between cholesterol and ceramide is affecting to the lysosomal stability and autophagy flux 
in the RPE under AMD illness (Toops et al., 2015). Not only in cellular models, but animal 
models have demonstrated that autophagy presents an important role in AMD. Rapamycin 
ameliorates the degenerative process in several animal models, such as a mouse with a 
deficiency in the mitochondrial respiration (Zhao et al., 2011a) and the OXYS rat 
(Kolosova et al., 2012). 
 
Aging causes retinal dysfunction as a consequence of retinal degeneration and loss of 
retinal cells (Militant and Lombardini, 2014). In humans, it has been observed that retinal 
dysfunction is associated with rod and cones loss (Weleber, 1981). Interestingly, aging is 
associated with a reduction of autophagy process and a decrease in the cleaning pathways, 
such as the ubiquitin proteasome activity (Martinez-Lopez et al., 2015). Our group has 
demonstrated that autophagy flux is decreased with aging in mouse (Rodriguez-Muela et 
al., 2012) as well as reduced mRNA expression of some autophgy-related genes, such as 
Atg7 and Beclin1; additionally, accumulation of p62, ubiquitin and lipofuscin was 
observed in mice from 12 and 22 months. These effects were comparable to Atg5flox/flox 
nes-cre, animals with a lack in Atg5 during the development. Interestingly, chaperone 
mediated autophagy (CMA) was increased in both animal models, suggesting a cross-talk 
between both types of autophagy to maintain cellular homeostasis (Rodriguez-Muela et al., 
2012). All of these mechanisms demonstrate the desvasting process of aging. To elucidate 
the mechanisms is important to prevent visual dysfunction associated to aging. 
 
1.4.5 Retinal dystrophies: Retinitis pigmentosa 
 
Retinitis pigmentosa (RP) is a group of heterogeneous and and inherited dystrophies 
mutations. Most cases of retinitis pigmentosa are monogenic but this disease is really 
heterogeneous genetically, in fact, investigators have identified at least 45 loci 
(http://www.sph.uth.tmc.edu/Retnet/disease.htm). Interestingly, these mutations cause a 
similar phenotype, characterized by photoreceptor degeneration and cell death. The 
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photoreceptor cell death leads to blindness. In humans, these diseases have an estimated 
incidence of 1 in 4.000 so it is classified as a rare disease (Rossmiller et al., 2012). The 
genes more known implicated in this disease are genes related to the phototransduction 
cascade, such us rhodopsin, rod cGMP-phosphodiesterase α-subunit or rod cGMP-
phosphodiesterase β-subunit; additionally, genes related to the vitamin A metabolism, such 
as ATP-binding cassete protein A4 or retinaldehyde binding protein; genes related to 
structural or cytoskeletal; genes related to signaling, (Fagerberg et al., 2014; Wang et al., 
2017).  
 
Some patients develop visual loss during their childhood, but most of the patients present a 
pattern of difficulties in the dark adaptation during the adolescence; later, they present loss 
of peripheral vision, tunnel vision and complete loss of the central vision by the age of 60. 
Rods, the photoreceptors in charge of the achromatic dark vision, are the first to die. After 
them, cones, the photoreceptors responsible for the colour vision and the acuity in light 
situations, also die during the seconday cell death. The ONL of the retina from the patients 
is dramatically thinner than a healthy retina. Several methodologies had been approached 
to identify retinitis pigmentosa in the patients: dark adaptation tests, contrast sensitivity, 
Slit-lap biomicroscopy or electroretinograms (ERGs).  This last technique is used either in 
human and mice. It is a technique that measures the electrical response of the retina based 
in giving flashes of light to the retina and harvest the information through an electrode. The 
expectations for the cure of retinitis pigmentosa are quite positive. Several treatments have 
been demonstrated to improve the phenotype of this disease. For example, patients 
administrated with vitamin A, vitamin E or both presented a better response in ERG test 
than those who were not taking vitamins (Clowes, 1993). Some of these recomedations can 
delay the neurodegeneration, but this disease has no cure yet.  
 
The photoreceptors respond to light due to opsin, a visual pigment, and retinal, a 
chromophore. Retinal isomerizes to trans for photon absorption. In that way, rhodopsin 
catalyzes the activation of transducin. This protein is a G-protein, which stimulates cyclic 
uanosine monophosphate phosphodiesterase (cGMP PDE) to catalyze cyclic guanosine 
monophosphate (cGMP). The decrease of cGMP induces a closure in the cGMP channels 
(Palczewski, 2006). But, in darkness, cGMP channels are open and transporting sodium 
and calcium to the inner of the cells. The influx of cations induces a depolizarization of the 
membrane.  
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Several animal models have been used to study retinitis pigmentosa. Some of the models 
are use due to their mutation occurs in the nature: dogs, cats and chicken. Additionally, 
several models are product of transgenic modifications, providing models of diseases to 
develop curative strategies: rat, mouse and pig. In this thesis, only one mouse model was 
used, the rd10 mice. The first retinal degeneration mouse model was the rd1 (rd from 
retinal degeneration) (Pittler et al., 1993). This model presents a mutation in the rod 
photoreceptor-specific phosphosidsterase gene Pde6b (Gargene et al., 2007). This mouse 
model presents a degeneration of the retina which begins at postnatal day P10. Retina is 
completely lost close to postnatal day P21 (Bowes et al., 1990). The rd10 mouse model 
presents a mutation in the same gene but the neurodegeneration is delayed. This mutation 
leads to an increase cGMP and cell death close to postnatal day P25 (Barhoum et al., 
2010). After 2 months of age, the mice are completely blind. This model provides a better 
pharmaceutical therapy due to the longer photoreceptor survival in comparison with rd1. 
There are more rd mouse model, such as rd4, with a chromosomic inversion; rd8, after a 
mutation in the gene CRB; or the rd16, with a depletion in a centrosomal proteins CEP290 
(Rivas and Vecino, 2009) 
 
Several therapeutic approaches have been tried in rd10 mouse model. For example, 
expression of human proinsulin in the mouse model rd10 is able to reduce cell death in the 
retina from the murine model. The human proinsulin decreased cell death and preserved 
visual response as determiend by ERG (Corrochano et al., 2008). Additionally, due to 
features observed in this mouse model, such us inflammation, microglial activation and 
reactive gliosis, the study of antagonists against the proneurotophin–p75NTR axis has been 
described (Platón-Corchado et al., 2017).  
 
1.4.6 Histone deacetylases in retinitis pigmentosa 
 
Histone acetylases (HATs) and histone deacetylases (HDACs) are enzymes that promote 
addition or removal of acetyls in lysine residues. These proteins were first known by 
relaxing chromatin structure and allowing access to transcription factors. In addition, 
recent studies have shown that these enzymes can also act in non-histone proteins and are 
implicated in cellular vital functions. In fact, HDACs have been considered as crucial 
target in several diseases, such as cancer, autoimmune or inflammatory diseases (Tang, 
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2013). The HDACs can be classified into four families: class I, compound by HDAC1, 2, 3 
and 8; class IIa, compound by HDAC 4, 5, 7 and 9; class IIb, compound by HDAC6 and 
10; and IV, compound only by HDAC11. In addition, there is another group of 
deacetylases called sirtuins or class III. HDACs are essential in the cellular homeostasis, 
although, interestingly, the pharmacologic HDAC inhibitors do not result in catastrophic 
effects. In fact, the HDAC inhibitors are well tolerated in vivo and block numerous disease-
associated gene expression (Haberland et al., 2009). In relation with our work, previous 
evidences in the rd1 mice have demonstrated that HDACs activity is increased in 
photoreceptors and this imbalance has an important role in rd1 photoreceptor degeneration. 
In this model, HDAC inhibition protects from photoreceptor death (Sancho-Pelluz et al., 
2011). 
 
Recent studies have shown that acetylation/deacetylation processes are implicated in 
autophagy, modifying the autophagy activity, in most cases, triggering autophagy. For 
example, SIRT1, one member of the sirtuin family, induces autophagy by deacetylating 
factors such as Atg5, Atg7 or LC3 in starvation conditions (Lee et al., 2008). In mouse 
embryonic fibroblasts, the deacetylation of p53 by HDAC1 induces autophagy (Contretas 
et al., 2013), and in Huntington disease, HDAC6 was established as a mediator of 
aggregates degradation by autophagy because of its interaction with microtubules (Iwata et 
al., 2005). These studies have demonstrated that deacetylation and autophagy are related 
processes, and this relationship could explain some disease-related effects. In addition, 
several evidences have demonstrated that acetylation can modulate the outcome and flux of 
autophagy (Bánreti, et al., 2013; Füllgrabe et al., 2013). HDAC research will help to ths 
scientific community to find out novel therapeutic pathways for retinal diseases. 
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2. OBJECTIVES 
 
The main objective of this thesis was to analyze the consequences of lysosome-dependent 
cell death in models of a neurodegenerative disease called Retinitis pigmentosa. In 
addition, we characterized the role of autophagy during lysosome-dependent cell death by 
using autophagy-deficient cell lines.  
 
For these aims, the following objectives were proposed: 
1. Determine the role of autophagy during photoreceptor neurodegeneration in a 
Retinitis pigmentosa mouse model, the Rd10 mice. 
2. Assess lysosome stability during neurodegeneration in the Rd10 retinas.  
3. Modulate autophagy and lysosomal activity during neurodegeneration to 
characterize the capacity of autophagy and lysosome to prevent or increase 
photoreceptor cell death.  
4. Develop an in vitro model by using the calcium ionophore A23187 to mimetize 
the Rd10 phenotype. 
5. Study the relation between lysosomal membrane permeabilization and 
autophagy at molecular level by using autophagy-deficient cell lines.  
6. Assess viability and lysosomal activity in autophagy-deficient cell lines, 
specifically in Atg5- and Atg7- deficient cell lines under conditions of 
lysosomal stress. 
7. Characterize the consequences of to lysosomal membrane permeabilization in 
autophagy-deficient cell lines.  
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3. MATHERIALS AND METHODS 
 
3.1 ANIMAL PROCEDURES 
3.1.1 MOUSE MODELS AND METHODS 
3.1.1.1 Mouse models and housing 
The CSIC and CIB ethics committee for animal experimentation approved the animal 
procedures used in this thesis. All the experiments were carried out in accordance with the 
European Union guidelines and the ARVO Statement for the Use of Animals in 
Ophthalmic and Vision Research. Wild-type and Rd10 mice are in C57BL/6J background 
and both strains were obtained from the Jackson Laboratory. The animals were exposed to 
12:12 light: dark cycles, temperature of 20 degrees, food and water ad libitum at the CIB 
animal facility. Both males and females were used for the experiments. To avoid the 
circadian variations of autophagy in the retina, samples were always obtained at the same 
hour: 10 am.  
 
3.1.1.2 Intravitreous and intraperitoneal injections 
Intravitreous injections were done with a Hamilton syringe (Model 75 RN SYR). For 
intravitreal trehalose treatment, P19 mice were anaesthetized with isoflurane. Right eyes 
were injected with 1 µl of 30 mM trehalose in PBS and left eyes were injected as controls 
with 1 µl of 30 mM sucrose in PBS. Mice were euthanized at P22 and eyes or retinas were 
extracted and fixed in 4% (w/v) paraformaldehyde (PFA) in 0.1 M phosphate buffer pH 7.4 
at 4 ºC overnight. Then, retinas were extracted and cell death detection was performed. In 
vivo rapamycin injections were performed from postnatal day P13 to postnatal day P23. 
The injections were done every two days. At P23, animals were sacrified and retinas were 
fixed with 4% PFA in 0.1 phosphate buffer at 4ºC. Then, TUNEL reaction was carried out 
as in apart 3.1.2.1. 
 
3.1.1.3 Neuroretina dissection 
Animals were euthanized by cervical dislocation and decapited. Eyes were enucleated and 
deposited in PBS. Using two dissection tweezers, neuroretina was separated from the 
pigmentary epithelium, sclera, crystalline and ora serrata.  
Matherials and methods  
 
 51 
For immunofluorescence, retinas were mounted in 0.44 µm nitrocellulose membranes 
(Sartorius, Göttingen, Germany) with the photoreceptors up. The mounted retinas were 
fixed in 4% PFA in 0.1 M phosphate buffer (PB), pH 7.14 overnight at 4 ºC or one hour at 
room temperature. After fixation, neuroretinas were washed with PBS 3 times for 5 
minutes each. Finally, they were kept in the fridge until the moment of the 
immunofluorescence. For western blot or qPCR, neuroretinas were frozen at -80 ºC until 
the protein or RNA extraction.  
 
3.1.1.4 Neuroretina organotypic culture 
Neuroretinas were cultivated in defined medium serum-free R16 medium, described by Dr. 
P. A. Ekstrom (Caffe et al., 2001) at 37 ºC and 5% CO2 for 24 hours. After that time, 
neuroretinas were mounted in nitrocellulose or they were frozen at -80 ºC. The treatments 
used in this thesis are in the table 1. 
 
Reactives Provider Reference Concentration Funtion 
A23187 Sigma C7522 5 µM Calcium ionophore 
ALLN Sigma 208719 20 µM Calpain inhibitor 
Leupeptin Calbiochem 108975 10 µM Cathepsin inhibitor 
Pepstatin A Sigma P5318 10 µg/ml Cathepsin inhibitor 
Rapamycin Calbiochem 553210 200 nM Autophagy inductor 
Table 1. Treatments used in the neuroretina organotypic culture. 
 
For autophagy flux assessment, neuroretinas were cultivated for 4 hours. One half was 
cultivated in vehicle in control medium, and the other half was cultivated with the 
lysosomal inhibitors: ammonium chloride (20 mM, Sigma, Missouri, USA) and leupeptin 
(100 µM, Calbiochem). After that, neuroretinas were froozen at -80 ºC until the protein 
extraction. 
 
3.1.1.5 Eye cryosections  
For cryosections studies, eyes were enucleated from the mice and fixed in 4% PFA 
overnight at 4 ºC. After that, eyes were washed 3 times with PBS and then the eyes were 
dehydrated by washes in sucrose diluted in 0.1 M phosphate buffer pH 7.14: 
- Sucrose 15% (w/v) during 1 hour in the shaker 
- Sucrose 30% (w/v) during 1 hour in the shaker 
Matherials and methods  
 
 52 
- Sucrose 50% (w/v) overnight in the shaker. 
If the samples were not used at the moment, eyes were frozen in sucrose 50%. Eyes were 
imbibed in OCT (Tissue Tek, Sakura Finetek, Tokyo, Japan) in an Eppendorf tube for 30 
minutes. After that time, eyes were placed in the Eppendorf lid with OCT to set up the eye. 
Eyes were oriented to get slices with optic nerve in the cryostat. Eyes were cut at 10 µm in 
a Leica CM 1800cryostat. The tissue sections were placed on glass slides (Superfrost® 
Plus, Thermo Scientific, Massachusets, USA). The tissue sections were kept at room 
temperature for 1 hour and then they were frozen at -20 ºC until immunofluorescence 
reaction. 
 
3.1.2 CELULAR TECHNIQUES 
3.1.2.1 Cell Death assay by TUNEL reaction 
Cell death assay was assessed in whole mounted retinas by using the terminal 
deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining. 
Mounted neuroretinas were washed with PBS after fixation. The chromatin was opened 
with citrate buffer, heating it up in the microwaves for 5 minutes. After three washes with 
PBS, neuroretinas were permeabilized with Triton®X-100 2% (v/v) in PBS four times 
during 20 minutes each. Neuroretinas were washed 3 times with PBS. Then, neuroretinas 
were permeabilized with BGT (3 mg/mL BSA, 10 mM glicine y 0.25% Tritón X-100 in 
PBS) 3 times 30 minutes each. Neuroretinas were washed with PBS. Neuroretinas were 
pre-equilibrated during 30 minutes in equilibration buffer at room temperature. Then, 
TUNEL reaction was done during 1 hour at 37 ºC as in the protocol from Promega 
(Madison, Wisconsin, USA). Then, the reaction was stopped by washes with PBS and 
nuclei were stained with 1µg/µl of 1, 4-diamino-2-fenilindol (DAPI). Neuroretinas were 
mounted with 1, 4 – diazabacycle (2, 2, 2) octane (DABCO, Sigma, Missouri, USA) and 
analyzed by confocal microscope TCS SP5 (Leica, Watzler, Germany). 
 
 
3.1.2.2 Quantification of cell death by TUNEL on mounted-retinas 
At least four pictures were taken with confocal microscopy from every neuroretina. The 
pictures were done in the ONL to include the photoreceptors and to avoid other cell types. 
Every picture was done at the same distance from the optic nerve. Only TUNEL positive 
cells were quantified. For the quantification, the maximal projections from sections of 1 
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µm were used. The software used in the quantification was ImageJ 1.6.0 (National Institute 
of Health, USA). 
 
3.1.2.3 Immunofluorescence in flat mounted retina 
Mounted neuroretinas were washed with PBS after fixation and then permeabilized with 
2% Triton®X-100 (v/v) in PBS four times during 20 minutes each, washed with PBS and 
blocked with BGT 3 times for 30 minutes and washed with PBS. Primary antibodies were 
incubated in 10% normal goat serum (NGS), 1% Triton®X-100 (v/v) in PBS overnight at 4 
ºC in a humid chamber (table 2). After 3 washes with PBS, neuroretinas were incubated 
with secondary antibodies with the specific fluorophore (table 3) in the same equilibration 
buffer for 2 hours at room temperature. After several washes, neuroretinas were incubated 
with DAPI for 1 hour at room temperature and mounted with DABCO for the posterior 
visualization at confocal microscope. 
 
 
3.1.2.4 Immunofluorescence in retina cryosections 
Criosection samples were left at room temperature 5 minutes. The samples were delimited 
with the Immunopen. Samples were refixed in 4% PFA during 15 minutes and washed. If 
the protein of study is attached to cellular membrane, samples were immersed in cold 
methanol for 5 minutes; if the antibody stain transcription factor, we used citrate buffer for 
5 minutes in the microwave. After several washes, samples were submerged in BGT 3 
times for 5 minutes each in a humidity chamber. After washing, samples were blocked by 
10% NGS, 1% Triton X-100 in PBS for 1 hour at room temperature. Primary antibodies 
were incubated in the same buffer overnight at 4C in the humidity chamber (table 2). After 
washing, secondary antibodies were incubated for 1 hour at room temperature (table 3). 
The nuclei were stained with DAPI as described before, and samples were mounted with 
DABCO. Samples were observed at the confocal SP5 Leica microscope. 
 
Antibody Provider Reference Species Dilution 
Anti-Ambra 1 Covalab CVL-PAB0224 Rabbit 1:100 
Anti-Cathepsin B Santa Cruz SC6490 Rabbit 1:50 
Anti-Galectin-3 BD 556904 Mouse 1:100 
Anti-Lamp1 DSHB 1D4B Rat 1:50 
Table 2. Secondary antibodies used in immunofluorescence of mounted or criosections of retinas. 
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Ab 2o Provider Reference Species Dilution 
Alexa 488 Invitrogen A11001 Polyclonal; Goat 1:200 
Alexa 568 Invitrogen A11004 Polyclonal; Goat 1:200 
Alexa 647 Invitrogen A21235 Polyclonal; Goat 1:200 
Table 3. Secondary antibodies used in immunofluorescence of mounted or criosections of retinas. 
 
3.1.2.5 Determination of cathepsin B activity by Magic Red reaction 
The activity of cathepsin B in the retinas was measured with Magic Red Cathepsin B 
Assay Kit (Immunochemistry Technologies, Minneapolis, USA). The Magic Red 
Cathepsin B Assay is a red fluorogenic cathepsin B substrate. Magic Red was added to the 
medium the last 30 minutes of incubation protected from the light, following the 
manufacturer´s protocol. After that, neuroretinas were mounted in nitrocellulose filters, 
fixed in 4% PFA in dark conditions during 1 hour at room temperature. Neuroretinas were 
incubated with DAPI as described before, and samples were observed at the confocal SP5 
Leica microscope.  
 
3.1.2.6 Detection of mitochondria levels by flow cytometry 
Mitochondria levels in the retina were studied by flow cytometry. Retinas from mice at 
postnatal day 20 and 30 were used for this assay. Neuroretinas were extracted from the 
eyes and placed in culture medium. Retinal cells were incubated with 0.5 mg/ml of trypsin 
(Worthington, Ohio, USA) for 5 minutes at 37ºC and dissociated by gentle pipetting. 
Trypsin effect was stopped by adding 1% (v/v) of FBS. Tubes were centrifuged at 450 g 
for 5 minutes. After decant the supernatant, retinas were incubated with 10 nM 
MitoTracker Deep Red (Thermo Fisher Scientific) in HBSS for 15 minutes at 37 ºC. At 
least 10.000 retinal cells were acquired in a FC500 flow cytometer (Beckman Coulter). 
Mean fluorescence in the FL4 channel of the live cell population was represented.  
 
3.1.3 BIOCHEMICAL TECHNIQUES 
3.1.3.1 Extraction and quantification of neuroretina proteins 
Appropriate volume of lysis buffer was prepared: 150 µl per complete retina and 75 µl per 
half of retina in flux autophagy studies. Lysis buffer is prepared in distilled water with 50 
mM of Tris-HCl pH 6.8, 10% of glycerol (v/v) and 2% Sodium Dodecyl Sulfate (SDS) 
(w/v), protease inhibitors (1 tablet for each 10 mL of buffer, Roche, Indianapolis, USA) 
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and phosphatase inhibitors (1 mM sodium orthovanadate, 5 mM sodium pyrophosphate, 1 
mM sodium fluoride). Retinas were scraped in 1.5 ml Eppendorfs with a syringe plunger. 
After vortex the homogenate, samples were warmed up at 95 ºC for 14 minutes. For 
protein quantification, 5 µl of every sample were diluted 1:5 in distilled water. The kit 
BCA Protein Assay (Pierce, Thermo Fisher Scientific Inc, Illinois, USA) was used for the 
quantification and was measured in a wavelength of 540nm.  
 
3.1.3.2 Immunodetection of proteins in membrane: Western blot 
A fraction of 15 µg of cell lysate was supplemented with 10 mM of dithiothreitol (DTT) 
and 0.005% (w/v) of bromophenol. The samples were loaded in CriterionTM TGX Precast 
Midi Protein gels (Biorad, California, USA) and transferred onto PVDF membranes 
(Biorad, California, USA) by using the Trans-Blot® Turbo™ Transfer System (Biorad, 
California, USA). The membranes were activated in methanol and blocked in 5% (w/v) of 
milk in PBS-Tween for one hour. After blocking, primary antibodies were incubated in 3% 
(w/v) BSA in PBS-Tween for 16 hours at 4 °C in the shaker. The primary antibodies used 
in this thesis are in the table 4. 
 
Ab 1o Provider Reference Species Dilution 
Anti-AKT Cell Signaling 9271 Rabbit 1:1000 
Anti-Calpain Calbiochem MAB3083 Mouse 1:1000 
Anti-COX4I1 Invitrogen 459600 Mouse 1:1000 
Anti-ERK Sigma M5670 Rabbit 1:500 
Anti-GAPDH Abcam ab8245 Mouse 1:2000 
Anti-Lamp2A Invitrogen 51-2200 Rabbit 1:1000 
Anti-LC3 Nanotools 0260-100 Rabbit 1:1000 
Anti-MAB Milipore MAB1273 Mouse 1:1000 
Anti-p62 ENZO PW9860 Rabbit 1:500 
Anti-PS6 Cell Signaling 4856 Rabbit 1:1000 
Anti-S6 Cell Signaling 2317 Mouse 1:1000 
Anti-TIMM23 BD 611222 Mouse 1:1000 
Anti-TOMM20 Santa Cruz sc-17764 Mouse 1:1000 
Anti-TOMM40 Santa Cruz sc-11414 Rabbit 1:1000 
Anti-tubulina Covance MMS-435P Rabbit 1:500 
Table 4. Primary antibodies used in retinal western blot. 
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After several washes with PBS-Tween, membranes were incubated with secondary 
antibodies conjugated for one hour at room temperature with peroxidase (DAKO P0448, 
Rabbit, Thermo Scientific 31430). Membranes were developed with the system Pierce 
ECL Blotting Substrate (Thermo Scientific, 32106) and using films Curix RP2 Plus film 
(AGFA). The films were digitalized and quantified with the software ImagJ 1.6.0. 
 
3.1.3.3 ATP assay: determination of ATP levels in retinas. 
ATP was quantified using the ATP Bioluminiscent Assay Kit HS II (Roche, Switzerland) 
in frozen retinas. 50 µl of dilution buffer and 50 µl of lysis buffer are added in each 
eppendorf, and incubated for 5 minutes at room temperature. After that, centifrugation was 
carried out for 1 minute at 10,000 X g at 4 ºC. 10 µl of the supernatant was diluted 1:2 with 
lysis buffer and quantified with the kit BCA Protein Assay (Pierce, Thermo Fisher 
Scientific Inc, Illinois, USA). The rest of the supernatant is used for measure ATP: 100 ng 
of every sample with 50 µl of dilution buffer in a plate with a black background. The 
measurement was done Measure the ATP in a Varioskan reader. 
 
 
3.2 CELL CULTURE 
3.2.1 MOUSE EMBRYONIC FIBROBLAST AND CANCER CELL LINES 
 
Large T-transformed mouse embryonic fibroblasts Atg5+/+, Atg5-/-, Atg7+/+ and Atg7-/- 
were kindly provided by Prof. Noboru Mizushima at the University of Tokyo (Japan) and 
Prof. Komatsu (Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan), 
respectively HeLa were obtained from the American Type Culture Collection (ATCC®, 
Rockville, Maryland, USA). The human breast adenocarcinoma cancer cell line MCF7 
were obtained from Dr. Marja Jäättelä´s laboratory (Danish Cancer Society Research 
Center, Copenhagen, Denmark). 
 
Mouse embryonic fibroblasts and HeLa were cultured in DMEN (Dublecco´s Modified 
Eagle Medium, GIBCO) supplemented with 10% FBS, 1% penicillin/streptomycin and 1% 
glutamine. MCF7 cell line was cultured with RPMI (GIBCO) supplement with 6% FBS 
and 1% penicillin/streptomycin. Cell lines were seeded at a density of 5.000-10.000 
cells/cm2 the evening before carry out the experiments. 
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3.2.2 IMMUNOFLUORESCENCE DETECTION 
3.2.2.1 Immunofluorescence of cells seeded in cover-slips  
Cells were seeded over sterilized glass cover-slips the day before the treatment. After the 
treatments, cover-slips were fixed with 4% PFA for 15 minutes and washed with PBS. The 
cover-slips were kept at 4 ºC. The permeabilization phase depends on the antibodies used. 
In general, 10% (v/v) SDS in PBS during 30 minutes was used for most of the antibodies. 
For proteins attached to membranes, cold methanol was used during 5 minutes for cleaning 
the cytoplasmic staining. After methanol permeabilization, 0.01% Triton 100X (v/v) in 
PBS was used. Primary antibodies were always incubated in 10% NGS and 1% Triton 
100X in PBS and incubated for 1 hour at room temperature or overnight at 4ºC (table 5).. 
After 3 washes with PBS for 5 minutes, secondary antibody was incubated for 1 hour at 
room temperature in 10% NGS (table 6).  
 
Ab 1o Provider Reference Species Dilution 
Anti-Cathepsin B Santa Cruz SC6490 Policlonal; Rabbit 1:50 
Anti-Galectin-3 BD 556904 Monoclonal; Mouse 1:100 
Anti-Lamp1 DSHB 1D4B Policlonal; Rat 1:50 
Anti-LC3 Sigma L7543 Policlonal; Rabbit 1:100 
Anti-p62 Progen GP62-C Policlonal; Guinea Pig 1:100 
Table 5. Primary antibodies used in immunofluorescence technique in cell lines.  
 
Ab 2o Provider Reference Species Dilution 
Alexa 488 Invitrogen A11001 Polyclonal; Goat 1:200 
Alexa 568 Invitrogen A11004 Polyclonal; Goat 1:200 
Alexa 647 Invitrogen A21235 Polyclonal; Goat 1:200 
Table 6. Secondary antibodies used in immunofluorescence technique in cell lines.  
 
After several washes with PBS, 1 mg/ml of DAPI was incubated for 15 minutes at room 
temperature. One last wash of PBS and cover slips were mounted with Fluoromont-G 
(Cultek, Spain) and stored at 4 ºC until confocal analysis. 
 
3.2.2.2 Lysosomal membrane permeabilization detection by galectin-3 
Cover-slips were fixed with 4% PFA for 15 minutes, washed three times with PBS and 
permeabilized with cold methanol for 3 minutes. After several washes with PBS, anti-
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galectin3 (BD, reference 556904; Mouse) as incubated for 2h at RT in 1% (w/v) BSA, 
0.3% (v/v) Triton 100X in PBS in a dilution of 1:100 After several washes with PBS-
Tween, secondary antibody was incubated in 1% (w/v) BSA, 0.3% (v/v) Triton 100X in 
PBS. After several washes of PBS-tween, nuclei were stained with 1mg/ml of DAPI and 
cover-slips mounted with Fluoromont G. Galectin-3 quantification was done in the 
microscope. Every cell had to present at least two galecin-3 puncta to be considered as a 
galectin-3 puncta positive cell.   
 
3.2.2.3 Lysosomal leackage by cathepsin B release 
To determine subcellular distribution of cathepsin B is a way to detect lysosomal 
membrane permeabilization. Cover-slips were fixed with 4% PFA for 30 minutes and 
cleaning three times with PBS. Cover-slips were permeabilized with cold methanol for 5 
minutes. After several washes with PBS, anti-cathepsin B (Santa Cruz, SC6490, polyclonal 
rabbit) was incubated in 10% (v/v) SDS in PBS in a dilution of 1:50 for 2 hours at RT. 
After several washes with PBS-Tween, secondary antibody was incubated in 10% (v/v) 
NGS, 0,1% (v/v) Triton 100X in PBS. After several washes of PBS-tween, nuclei were 
stained with 1mg/ml of DAPI and cover-slips mounted with Fluoromont G. Cathepsin B 
quantification was done in the microscope. To consider one cell as positive, cathepsin B 
should appear as diffuse staining and not in dots. Colocalization with other antibody 
against lysosomal protein is a good option to detect if cathepsin B is outside lysosomes. 
 
3.2.2.4 Acidic compartments staining: LysoTracker 
LysoTracker is a fluorophore, which stains acidic compartments in cells. To study acidic 
compartments by immunofluorescence, 1 µM LysoTracker Red (Invitrogen, L7528) was 
added to the well in the last 30 minutes of the treatment. After this incubation, cover-slips 
were fixed with 4 % PFA during 30 minutes. Nuclei was stained with 1 mg/ml DAPI and 
cover-slips mounted with Fluoromont G. 
 
3.2.2.5 Quantification of microscopy confocal images 
Images from confocal were quantified with ImageJ 1.6.0 (National Institute of Health, 
USA). Java program was used to perform a protocol. The protocol was setting depending 
on the antibody. To perform the protocol, we performed a Java protocol. After that, the 
protocol was run automatically in ImagJ.  
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3.2.3 PROTEIN DETECTION OF MOUSE EMBRYONIC FIBROBLAST 
3.2.3.1 Protein extraction 
Cells were seeded in 6-well plate the day before carrying out the experiment. After the 
transfection or treatment, proteins were extracted from the plate by using 150 µl of lysis 
buffer.  Lysis buffer was prepared as described in 3.1.3.1. The proteins were scraped with a 
syringe plunger and transferred to 1.5 ml Eppendorfs. Samples were warmed up at 95ºC 
for 14 minutes. The quantification of the cellular proteins was done as described in 3.1.3.1. 
 
3.2.3.2 Immunodetection of proteins in membrane: western blot 
The immunodetection of cellular proteins in membrane was done as described in 3.1.3.2. 
 
3.2.4 TRANSMISSION ELECTRON MICROSCOPY 
 
300,000 cells were seeded in 6 well plates. After the treatment, medium was removed and 
cells were washed with PBS and fixed with 3% glutaraldehyde (v/v) in PBS for one hour. 
After fixation, cells were washed with PBS. Cells were refixed with osmium 1% and 
ferricianure 0.8% in PBS for one hour. After PBS washes, cells were dehydrated with 
ethanol washes, from 30% to 100% gradually. Cells were infiltrated with epoxy LX 112 
resin. Cells were polymerized for 24 hours at 60C. Ultramicrotomy and contrast with 5% 
of uranile acetate in PBS and lead citrate (Reynolds). The samples were visualized in 
transmission electron microscopy 1230 80kv with camera TVIPS 4KxK. 
 
 
3.2.5 FLOW CYTOMETRY 
25,000 cells were seeded in a 24-well plate the day before the experiment. After the 
treatment, wells were washed with 200 µl of PBS, and cells were detached with 200 µl of 
Trypsin (Thermo Fisher Scientific) at 37 ºC for 5 minutes. Trypsin action was stopped with 
400 µl of serum-containing medium and the samples were transferred to cytometer tubes. 
After, tubes were centrifuged for 5 minutes at 140 g, medium was removed and medium 
with 1µM of propidium iodide (Sigma, P4864) was added. Death population was plotted. 
At least, 10,000 cells were adquired in a FC500 flow cytometer (Beckman Coulter).  
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3.2.6 DETECTION OF GENE EXPRESSION 
3.2.6.1 Extraction of messenger RNA 
300,000 cells were seeded in 6-well plate in a high confluency. After the treatments, 
cultures were stopped with TRIzol® Reagent (Thermo Fisher Scientific). Cell extract was 
moved to Eppendorfs and this extracted was passed 10 times through syringes of 0.8mm x 
25 mm. Chloroform was added in the Eppendorf and cell extract was centrifuged at 1,400 
g during 15 minutes at 4 ºC.  Supernatants were kept and glycogen (Fisher, reference 
10814010) and isopropanol was added. After gentle shaking, cells were centrifuge at 1,400 
g for 10 minutes at 4C. Supernatant was removed and the samples were cleaned with 
ethanol 70% and centrifugated at 60 g, 5 minutes at 4C. Ethanol was removed and when 
the pellet was dry, samples were resuspended in RNase free water. To increase the 
solubility, samples were heating at 55 ºC. RNA amount was quantified in Nanodrop and 
stored at -80 ºC until use. 
 
3.2.6.2 Reverse transcriptase reaction  
The qRT-PCR was done in groups of 6 samples. 1 µg of RNA was retrotranscribed to 
cDNA by using the High-Capacity cDNA Reverse Transcription Kit with RNase Inhibitor 
(Applied Biosystems, Waltham, MA, USA) in a final volume of 13,2 µl. The next reactives 
were added to every sample: 2 µL buffer 10X, 2 µL  Random Primers 10X, 0.8 µL de 25x 
dNTP Mix (100mM), 1 µL MultiScribe® Reverse Transcriptase (50 U/µL) and 1 µL of 
RNAse inhibitor (20 U/µL). The samples were mixed and the reaction was done in the 
thermocycler Light Cycler® 480 Instrument (Roche Diagnostics, Mannheim, Germany) 
with the next program: 25 ºC for 10 minutes, 37 ºC for 120 minutes, 85 ºC for 5 minutes 
and 4 ºC as final step.  
 
3.2.6.3 Quantitative PCR 
Taqman oligonucleotides for selected genes were designed according to the Roche 
software for quantitative real-time PCR (Roche Diagnostics, Mannheim, Germany).  
Assays were made in experimental duplicate and results normalized according to the 
expression levels 18S. The results were expressed using the method ΔΔCT (cycle 
threshold). The tagman oliglonucleotides used are shown in the table 7. 
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Gen Taqman Reference 
Lamp1 Mm00495262_m1 
Maplc3b Mm00458725_gl 
Sqstm Mm00448091_m1 
TFEB Mm00448968_m1 
Table 7. Probes and references used for the qRT-PCR.  
 
3.2.7 CELL LINE TRANSFECTION  
300.000 cells were seeded in a 6-well plate the day before. Medium was removed and 
OPTIMEN was added to the wells. Transfection was done with 2 µg of DNA incubated 
with lipofectamin. After 25 minutes of incubation of DNA and lipofectamin, 400 µl of the 
mix was added to every well. After 4 hours, OPTIMEN medium was removed and, 
depending on the experiment, complete medium was added to the cells or cells were raised 
and seeded in a new plate.  
 
 
3.2.8 LIPIDOMIC STUDY 
For the lipid extraction, 1,2 millon cells were centrifuged at 140 g during 5 minutes. Cells 
were washed with Ammonium Acetate (Sigma) in H2O and then centrifuged for 5 minute 
each, at 400X g and 4 ºC. The lipidomic service of the Danish Cancer Society Research 
Centre studied the lipidomic profile through HPLC.  
 
3.3 STATISTICAL ANALYSIS 
The data presented in this thesis was analyzed with the SPSS 21.0 software. If the samples 
were normal and homoscedastic, the comparision of means statistical significance was 
evaluated using the Student t test or analyzed with of variance analysis (ANOVA). In all 
cases, p<0.05 was considered stadistically significative. The data are represented as the 
means of the population ± the standar error from 3 independent experiments with 
triplicates.  
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4. RESULTS 
4.1 RD10 MOUSE MODEL: AUTOPHAGY AND LYSOSOME-DEPENDENT 
CELL DEATH IN RETINITIS PIGMENTOSA MODEL  
 
4.1.1 Rd10 retinas display photoreceptor cell death 
 
Previous results in the Rd1 mouse model had demonstrated that the cell death is associated 
to calcium accumulation (Sancho-Pelluz et al., 2008) as phosphodiesterase mutation in this 
strain keeps calcium channels in the open conformation. To address this process in the 
Rd10 mouse model, a time-course of the intracellular calcium levels was performed. 
Previous data from our lab demonstrated that the peak of cell death in the Rd10 is at 
postnatal day P25. Wild-type and Rd10 retinas were used from animals at different ages: 
postnatal day P14, P18, P21 and P25. The retinas were dissociated and stained with Fluo-3 
and analyzed by flow cytometry.  
 
Figure 4.1 Rd10 retinas present an intracellular calcium influx. (A) Determination of the percent of cells 
with increased intracellular calcium in the retina at different postnatal days. Relative values ± SEM (*p<0.01, 
***p<0.001). (B) Representative histogram of the levels of Fluo-3 in whole retinas from wild-type and Rd10 
animals.  
 
Analysis of Fluo-3 staining revealed a significant increase in the intracellular calcium 
influx in the Rd10 retinas from postnatal day P18. The number of cells with increased 
intracellular calcium levels is significatively higher in Rd10 than in wild-type from 
postnatal day P18 (figure 4.1A). As expected the fluorescence of Fluo-3 is higher in Rd10 
retinas than in the wild-type retinas (figure 4.1B). These data indicated that calcium 
increase happens before the cell death peak. 
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Observing the increase of intracellular calcium in the Rd10 retinas, and due to the relation 
between intracellular calcium and the activation of the calpain family protein, 
immunoblotting of wild-type and Rd10 retinas at different postnatal days was performed to 
study the activation of calpain family proteins. The ages selected were: P15, when 
neurodegeneration was starting, P20, several days before the cell death peak; and P25, 
when the cell death peak was taking place. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Activation of calpain-2 in the Rd10 retinas. Immunoblotting from retinal lysates from wild-
type (Wt) and Rd10 retinas at postnatal day P15, P20 and P25. Every lane represent one different animal.  
 
 We observed that Rd10 retinas present cleaved calpain-2 at postnatal day P20 and P25 
(figure 4.2), suggesting the calcium-induced calpain activation. 
 
4.1.2 Autophagy in rd10 retinas 
 
4.1.2.1 Detection of basal autophagy in Rd10 retinas  
We were interested in understanding the dynamic of autophagy during the 
neurodegeneration in Rd10 retinas. To study the role of autophagy in a mouse model of 
retinal degeneration several autophagy related protein expression was assessed in wt and 
rd10 mice at different time postnatal days: P20, P30 and P60. 
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Figure 4.4 Autophagy study in wild-type and Rd10 retinas. Immunoblot of autophagy-related proteins in 
extracts from wild-type and Rd10 retinas. Animals were sacrificed at different ages: P20, P30 and P60. Every 
lane represented one retina representative from animal. 
 
At postnatal day P20, before the cell death peak, LC3-II levels were decreased in Rd10 in 
comparison with wild-type retinas (figure 4.4). Alternatively, p62, which is an autophagy 
substrate, is increased in the Rd10 retinas, suggesting autophagy blockade. In addition, this 
reduction of LC3-II is more pronounced in postnatal day P30 Interestingly, the levels of 
LC3II dissapered at postnatal day P60, suggesting that most of the autophagy process is 
taking place in the rods, as no rods are left at P60. Furthermore, the autophagy blockade 
was confirmed by the activation of mTOR as is evidenced by the increase in the 
phosphorylation of S6 in the Rd10 retinas. Interestingly, an increase in Lamp2A was 
observed in the Rd10 retinas at postnatal day P20 and P30. In conclusion these data 
suggest a block in autophagy in the rd10 retinas. 
 
These data were confirmed by assessing the retinas of rd10 mice crossed with the GFP-
LC3 mouse. Figure 4.5 shows decrease GFP-LC3 staining in the ONL of rd10 retinas. In 
addition, Ambra1 staining was also reduced in retinal sections from GFP-LC3 and Rd10-
GFP-LC3 animals at postnatal day P25. 
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Figure 4.5 Staining of autophagic proteins was observed in Rd10-GPF-LC3. The retinal cryosections 
were stained with Ambra 1 (cyan) and DAPI (blue). LC3 is observed in green. Scale bar, 45 µm. GCL, 
ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, 
outer nuclear layer; OS, outer segment.  
 
 
GFP-LC3 retinas presented a uniform pattern of LC3 staining in the ONL and the GCL. 
Moreover, Ambra1 was observed in the OS, INL and GCL. However, Rd10-GFP-LC3 
cryosections presented a non-ubicuous GFP signaling and more accumulated in the ONL 
(figure 4.5). Moreover, Ambra1 appeared more concentrated in the GCL. 
 
 
4.1.2.2 Detection of Autophagy flux in Rd10 retinas 
To assess in autophagy flux in Rd10 retinas, LC3-II was studied after lysosomal inhibition 
using protease inhibitors. For that goal, levels of autophagic proteins were studied after 24 
hours of culture with proteases inhibitors: Pepstatin A, E-64d and Leupeptin A. For this 
experiment, whole retinas from wild-type and Rd10 animals at postnatal day P20 were 
incubated ex vivo in the presence and absence of protease inhibitors. Western blot was 
performed with the samples. 
Results 
 
 70 
 
Figure 4.6 Western blot of autophagic proteins after 24 hours of incubation with protease inhibitors. 
Autophagy-related protein levels in the whole retina from wild-type and Rd10 of postnatal day P20. Every 
lane represented one retina.  
 
The figure 4.6 clearly shows that the levels of LC3-II in the Rd10 animals at postnatal day 
P20 do not increase in the presence of protease inhibitors while it did in wild-type retinas. 
This indicates that there is no autophagy flux in the Rd10 retinas. Moreover, Akt and 
phospho-Akt present similar levels of protein in wild-type and Rd10. Interestingly, 
phospho-ERK present an increase in Rd10 retinas, suggesting the activation of MAPK 
pathway, a well-known pro-survival signalling before degeneration.  
 
We next assessed whether the block in autophagy flux was observed at different time 
points during neurodegeneration. For this experiment, half of the retinas were incubated in 
absence of protease inhibitors; the other halfs were incubated for 3 hours in “N/L” 
medium: fresh medium with Ammonium Chloride and 100 µm Leupeptin A. To confirm 
the autophagy flux blockade at different ages, wild-type and Rd10 retinas were isolated 
from animals from three different postnatal days: P16, P20, and P24. 
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Figure 4.6 Autophagy and autophagy flux in wild-type and Rd10 retinas. Immunoblotting of LC3-I and 
LC3-II after 3 hours of ammonium chloride and Leupeptin (N/L) from isolated retinas from animals at 
postnatal day P16 (A), P20 (B) and P24 (C). Every lane represented the half of the retinal cultured in absence 
of presence of N/L.Autophagy flux: LC3-II divided by GAPDH, and the coefficient between samples with 
N/L and control. 
 
Differences in LC3-II protein levels were observed between protease inhibitor and N/L 
technique, being N/L more efficient blocking the autophagy flux. Moreover, wild-type 
retinas at postnatal day P16 presented an active autophagy flux, unlikely in the Rd10 
retinas (figure 4.6A). Interestingly, the LC3-II protein levels become more similar to the 
wild-type retinas when the cell death peak was close at P20, but the variation in Rd10 
retinas is elevated (figure 4.6B) and even more similar at P24 (figure 4.6C). In conclusion, 
autophagy flux was blockade before  neurodegeneration. 
 
 
4.1.3 Rd10 retinas present higher levels of mitochondria  
 
The autophagy block observed in the rd10 retinas could be affecting the selective 
degradation of organelles such as mitochondria during mitophagy. For this reason, 
oxidative stress was studied by staining the retinas with dihydroethidium (DHE). DHE 
exhibits blue-fluorescence in the cytosol until oxidized, where it intercalates with cell's 
DNA, staining its nucleus a bright fluorescent red. After staining, retinas were studied by 
flow cytometry.  
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Figure 4.8 Rd10 retinas exhibit an increased in oxidative stress. Oxidative stress determination by using 
DHE staining.Histogram  shows  profile  of  Wt  and  rd10  retinas  at  P23  and  the  graphs display  the  
quantification  at  different  ages  (*** p<0.005,  n=4).   
 
 
As it is shown in figure 4.8, Rd10 retinas have a significative increase in the levels of 
oxidative stress at postnatal day P23. After this result, mitochondria levels were studied by 
using MitoTracker Deep Red (MTDR) and probing for the staining by flow cytometry 
using a method recently described by our lab (Mauro-Lizcano et al., 2015) using wt and 
rd10 retinas at day P20 and P30.  
 
Figure 4.9 Levels of MTDR in complete retinas. The graphics represent the levels of MTDR relatively to 
wild-type retinas from the same age. (A) MTDR levels from postnatal day 20 retinas from wild-type and 
Rd10 animals. Mean ± SEM represented from 8 retinas per condition in 2 independent experiment. (B) 
MTDR levels from wild-type and Rd10 animals from postnatal day P30. Mean ± SEM represented from 8 
retinas per condition in 2 independent experiments. ** p-value <0.01 
 
Rd10 retinas displayed more MTDR fluorescence levels by flow cytometry that wild-type 
retinas at postnatal day P20 (figure 4.9A) and P30 (figure 4.9B). To verify these data by 
other method, we isolated retinas from wild-type and Rd10 mice from postnatal day 20 and 
30 and evaluated the levels of mitochondrial proteins such as: COX4I1, TIMM23, 
TOMM20, and TOMM40 by immunoblotting. 
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Figure 4.10 Mitochondrial proteins from wild-type and Rd10 retinas. Retinas from wild-type and Rd10 
at postnatal day 20 and 30 were used to study mitochondrial protein levels. Every lane represented a different 
animal.  
 
The immunoblotting demonstrated that COX4I1 and TOMM20 protein levels were higher 
in the Rd10 retinas than in the wild-type (figure 4.10). Moreover, protein level of 
TIMM23 was increased in the Rd10 retinas. These data demonstrated that Rd10 retinas 
presented increased mitochondrial protein levels. To gain insight into these results, 
mitophagy and mitophagy flux were studied through two approaches: mitochondrial 
protein levels were studied by western, and inducing/blocking mitophagy with mitophagy 
inductors, such as CCCP; and mitophagy inhibitors, such as Ciclosporin A or FK506.  
 
First of all, mitophagy flux was studied by immunoblotting after culture of Leupeptin A, 
E64d and Pepstatin A for 24 hours. For this aim, whole retinas from wild-type and Rd10 
animals from postnatal day P20 were incubated in medium in the absence or the presence 
of the proteases inhibitors.  
 
Figure 4.11 Mitochondrial protein from extracts of retinas incubated with protease inhibitors. 
Mitochondrial proteins from whole retinas of wild-type and Rd10 animals of postnatal P20 after 24 hours of 
culture in absence or present of Leupeptin A, E64d and Pepstatin A. Every lane is an individual retina. Prot 
Inh: protease inhibitor. 
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The levels of the mitochondrial proteins MAB, COX4I1 and TIMM23 were not increased 
in the retinas after 24 hours of incubation with protease inhibitors (figure 4.11). 
 
Next retinas from wild-type animals were cultured with CCCP (25 µM), a mitophagy 
inductor; and CsA (10 µM) and FK, mitophagy inhibitors to confirm that there was no 
mitophagy in the retina. Wild-type retinas from animals at postnatal day P20 were isolated 
and cultured with the respective drugs. After the culture, retinal cells were dissociated, 
stained with MTDR and studied by flow cytometry.  
 
Figure 4.12 Basal and induced mitophagy in wild-type retinal. (A) Wild-type retinas at postnatal day 20 
were treated with CCCP 25 µM for 24 hours to induce mitophagy. (B) Wild-type retinas at postnatal day 20 
were treated with CsA and FK for 24 hours to block basal mitophagy. In total, 12 retinas were used in 4 
different experiments for each basal and induced studies. No significative differences were observed. Mean ± 
SEM represented. 12 retinas per 4 independent experiments.  
 
No mitophagy induction was observed in wildtype retinas after 24 hours of CCCP (figure 
4.12A). Moreover, no increase of MTDR was observed after treatment with CsA and FK 
(figure 4.12B). The analysis of mitochondrial levels after mitophagy induction and 
mitophagy inhibition demonstrated that mitophagy was not happening in the wild-type 
retinas. But, as commented previously, Rd10 presented more mitochondrial protein levels, 
which could indicate an induction of mitochondrial biogenesis. Further experiments need 
to be done to understand mitochondrial dynamic in the Rd10 retinas. 
 
4.1.3.1 ATP levels in rd10 retinas 
Due to the difference in the mitochondria levels in the Rd10 retinas, ATP levels were 
studied in the whole retina comparing Rd10 mouse model to wild-type. For this 
experiment, wild-type and Rd10 animals of postnatal day 20 were used.  
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Figure 4.13 Study ATP levels in wild-type and Rd10 retinas. This table is representing fentomoles of ATP 
in the complete retina from wild-type and Rd10 retinas. Mean ± SEM represented. 6 animals per genotype 
were used in this study.    
 
The mean of the levels of ATP were higher in the Rd10 retinas than in the wild-type 
retinas (figure 4.13). As commented previously, Rd10 presented more mitochondrial 
protein levels and the retinas present a tendency displaying more ATP, which could 
indicate an induction of mitochondrial biogenesis or that rod have less mitochondria than 
cones, and since the rd10 retinas are enriched in cones due to rod death. These possibilities 
wait for further investigation. 
 
4.1.4 Lysosomal membrane permeabilization in rd10 retinas 
 
4.1.4.1 Colocalization of immunofluorescence of lysosomal markers 
In order to understand why the Rd10 retinas displayed alterations in autophagy flux and 
due that calpain activation has been described to induce lysosomal damage, we decided to 
investigate whether lysosomes were altered in the Rd10 retinas. To detect whether the 
Rd10 mouse model presented lysosomal damage, retinas from wild-type and Rd10 animals 
from postnatal day P20 were stained with Lamp1, a lysosomal membrane protein, and 
Cathepsin B, a lysosomal protease able to be active in the cytosol. Colocalization of both 
proteins was studied in the Rd10 system and in the wild-type model by confocal 
microscopy. 
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Figure 4.14 Immunofluorescence of lysosomal proteins in wild-type and Rd10 retinas. Staining of 
Cathepsin B (red) and Lamp1 (cyan) in mounted retinas of wild-type and Rd10 retinas at postnatal day P20. 
White narrows point the colocalization between both proteins. Scale bar 25 µM. 
 
Rd10 retinas presented less colocalization between the lysosomal membrane protein, 
Lamp1, and the lysosomal protease, cathepsin B. These results suggested that the Rd10 
retinas presented less colocalization between lamp1 and cathepsin B in the lysosomes 
(figure 4.14). 
 
4.1.4.2 Magic-Red staining to study cathepsin B activity  
To determine whether Rd10 retinas presented less cathepsin B in the lysosomes, cathepsin 
B activity assay was carried out. For this goal, retinas from wild-type and Rd10 at 
postnatal day P20 were cultured with magic red, a fluorogenic cathepsin B substrate that 
display red fluorescence. After the culture, retinas were flat mounted and observed by 
confocal microscopy. 
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Figure 4.15 Magic red assay in wild-type and Rd10 retinas. Wild-type and Rd10 retinas were cultured 
with magic red, the fluorogenic cathepsin B substrate. Only outer nuclear layer was assessed by performing 
the maximal projection of the z-stack of the ONL. Three experiments, 4 animals each condition. Scale bar 25 
µm. 
 
Magic red staining presented puncta staning in the wild-type retinas, suggesting the 
lysosomal distribution of cathepsin B; alternatively, the Rd10 retinas presented a 
cytoplasmic and more intense magic red staining in comparison with the wild-type retinas 
(figure 4.15). This experiment commended that the localization of cathepsin B was 
cytosolic in the case of the Rd10 retinas due to the cytosolic staining. Additionally, this 
staining suggested that the enzyme was still being active even in the cytosol. These 
experiments suggested that the Rd10 retinas present LMP in the photoreceptors.  
 
4.1.4.3 Galectin-3 to detect LMP  
To further gain insight into the lyosomal damage in the Rd10 retinas, we used a recently 
and powerful methods by assessing LMP with galectin-3 staining in cell cultures (Aits S, et 
al.). Galectins are proteins with high affinity for the β-galactoside sugars (Barondes, et al.). 
Galectins are usually presented in the cytosol, but when lysosomes are permeabilized, 
galectins can go inside lysosomes and bind to the β-galactoside sugars from the lysosomal 
membrane. LMP can be studied by doing an immunofluorescence for galectin-3.  
 
To assess if this technique was valid in retinas, wild-type retinas were treated with 
terfenadine, a cationic amphiphilic drug (CAD) well-known to induce LMP in cell lines. 
After 24 hours of culture, cathepsin B immunofluorescence was studied to analyze whether 
terfenadine was inducing LMP in the retinal system.  
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Figure 4.16 Immunofluorescence of Cathepsin B in wild-type mounted retinas. Wild-type retinas were 
incubated for 24 hours in the absence and presence of terfenadine. Scale bar 25 µm. 
 
The immunofluorescence of cathepsin B after the treatment with terfenadine showed that 
the treatment with the CAD was affecting to the localization of the lysosomal protease 
cathepsin B in the retinas. The pictures demonstrated that terfenadine was inducing 
lysosomal damage in the retina due to the diffuse cathepsin B staining after terfenadine 
treatment in comparision with control (figure 4.16). For this reason, wild-type retinas 
treated with terfenadine were stained with galectin-3 and Lamp1. 
 
Figure 4.17 Immunofluorescence of galectin3 and lamp1 of mounted retinas. Mounted retinas from wild-
type mice at postnatal day P20 were stained for galectin-3 and Lamp1 after 24 hours of absence or presence 
of terfenadine. White narrows indicate colocalization between galectin-3 and lamp1. Scale bar 25 µm. 
 
 
Interestingly, control mounted retinas presented higher levels of colocalization between 
galectin-3 and lamp1 (figure 4.17). However, treated retinas with terfenadine present a 
decrease in lamp1 protein levels. Slices of retinas were studied to determine in which layer 
the colocalization of lamp1 and galectin-3 was happening. For that goal, wild-type retinas 
were cultured in control medium and terfenadine for 24 hours. After that, retinas were 
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fixed and immunofluorescence was carried out. In the microscope, slices of XZY were 
done to characterize the layers of the retinas. 
 
Figure 4.18 Colocalization of Lamp1 and galectin-3 in slices of cultured retinas. Immunofluorescence for 
galectin-3 and Lamp1 was completed in retinas after 24 hours of terfenadine treatment. GCL, ganglion cell 
layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear 
layer; OS, outer segment. 
 
The XZY layout leaded us to observe the immunofluorescence in every layer (figure 4.18).  
The colocalization of galectin-3 and Lamp1 was observed in the ganglion cell layer in the 
control retina. Additionally, the staining of galectin-3 and lamp1 after terfenadine 
treatment was higher when the retinas were observed in XZY layout. Interestingly, 
terfenadine treatment is inducing galectin-3 colocalization with lysosomes, but it is only 
observed in slices. Subsequently, Rd10 animals were studied to conclude if galectin-3 was 
a precise method to study LMP in the retina system. 
 
Immunofluorescence of galectin-3 was studied in retinas from Rd10 animals at postnatal 
day P20. Retinas were isolated, immunofluorescence was done and mounted retinas and 
retinal slices were observed in the confocal microscopy.  
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Figure 4.19 Immunofluorescence of galectin-3 in Rd10 retinas. Rd10 animal of post-natal day P20 were 
stained for galectin-3 (green) and DAPI (blue). (A) Slices of retinas from Rd10. (B) Pictures from GCL, INL 
and ONL. Scale bar 50 µm. Two experiments with 3 animals each. 
 
Interestingly, the signaling of galectin-3 was observed in the GCL of the Rd10 retinas 
(figure 4.19). It has not been described that GCL presented LMP. In addition, ONL did not 
presented galectin-3 staining. Together these data show that galectin-3 cannot be used as a 
precise method to assess LMP in retinal tissue, as it is working in cells (see appart 4.2.1.1). 
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4.1.5 A23187-treated retinas: mimicking the rd10 model in wild-type retinas  
 
4.1.5.1 Detection of cell death levels in A23187-treated wild-type retinas 
The A23187 is a calcium ionophore procedent from the bacterial Streptomyces 
chartreusensis. A23187 interacts with Mn2+, Ca2+ and Mg2+, allowing them to cross the 
membrane to the cytoplasm increasing intracellular Ca2+ levels. In this thesis, A23187 has 
been used as a model for the Rd10, as it mimic the calcium increase found in these mice 
and in patients with retinitis pigmentosa. Calcium levels were studied in wild-type and 
A23187 treated retinas in comparison with Rd10 retinas.  
 
Figure 4.20 A23187 treatment induced similar levels of calcium as Rd10 retinas. (A) Flow cytometry 
analysis of calcium levels using Fluo-3AM in P20 wild-type retinas cultured for the indicated times with 
either vehicle (DMSO) or the calcium ionophore A23187. (B) P20 Wt and rd10 retinas were incubated in 
parallel with Fluo-3AM for comparison. *p<0.05, n=4. 
 
A23187 treatment was inducing similar calcium levels as in Rd10 retinas (figure 4.20). 
After this result, cell death levels were studied by TUNEL reaction and compare it with the 
levels in the Rd10 retinas at the peak of cell death. For this aim, wild-type retinas were 
treated with A23187 for 24 hours. After that, TUNEL reaction was carried out.  
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Figure 4.21 A23187 treatment is inducing cell death in wild-type retinas after 24 hours. (A) TUNEL 
reaction in mounted retinas. Scale bar 50 µm. (B) Quantification of TUNEL positive cells. Mean ± SEM of 4 
retinas per condition of 4 independient experiments. (*** p<0.001). Student´s test. 
 
A23187 treatment in retinas was inducing cell death in the wild-type retinas in a 
significative manner (figure 4.21A and 4.21B).  
 
4.1.5.2 Autophagy blockade in A23187-treated wild-type retinas 
Because of the autophagy blockade in the Rd10 retinas, autophagy protein levels were 
studied in A23187-treated retinas. For that aim, retinas from wild-type animals of postnatal 
day 20 were isolated and cultured for 24 hours with 5µM A23187. The contralateral retinas 
were cultured with protease inhibitors (Pepstatin A, E64d and Leupeptin) in order to 
measure autophagy flux. After the culture, the immunoblotting of autophagy-related 
proteins was developed.  
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Figure 4.22. A23187 was inducing a decrease in autophagy-related proteins levels in wild-type retinas. 
Western blot from retinas of postnatal day 20 after 24 hours of A231287 treatment. Every lane represents one 
retina from different animals. The protease inhibitor treatment was done with retinas from the same animal. 
This is a representative image of three different experiments where 9 animals were used in total. “Prot inh”: 
protease inhibitors.  
 
A23187 treatment induced a decrease in LC3-II (figure 4.22), indicating that A23187 
induces an autophagy blocked. Indeed, LC3-II reduction is still present in the combined 
treatment of A23187 and proteases inhibitors, demonstrating that autophagy flux is 
blocked with A23187. In conclusion, A23187-treatment induces basal autophagy and 
autophagy flux blocked, similarly to the phenotype observed in the Rd10. Additionally, 
A23187 treatment affected to the AKT and ERK protein levels. The decrease of protein 
levels of AKT and ERK could be related with the decrease of cellular viability, as it has 
been demonstrated in the section 4.1.6.1. Furthermore, A23187 treated retinas presented an 
increase in p-S6 protein level, which implicate an autophagy blockade (figure 4.22). These 
results demonstrated that A23187 treatment induced autophagy blockade, in agreement to 
the Rd10 mouse model phenotype.  
 
4.1.5.3 Lysosomal leackage in A23187-treated wild-type retinas 
To address if the A23187 treatment in the wild-type retinas was inducing LMP we next 
assessed cathepsin B activity. Wild-type retinas were treated with A23187 for 24 hours. 
After the treatment, retinas were stained with Magic Red, mounted and studied in confocal 
microscopy.  
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Figure 4.23. Study of the cathepsin B activity in A23187 treated retinas. Images from confocal 
microscopy from wild-type retinas after 24 hours of A23187 treatment stained with Magic Red (red) and 
DAPI (blue). White narrows indicate cytoplasmic magic red staining. Bar scale 20 µm.  
 
A23187 treatment in wild-type retinas induced a nuclear Magic Red staining (figure 4.23). 
The cathepsin B activity was observed in the whole cell and not exclusively in the 
lysosomes, as in the control condition. These results suggested that A23187 treatment was 
inducing LMP in the wild-type retinas.  
 
4.1.5.4 Autophagy modulation in A23187-treated wild-type retina 
The A23187 treatment was a worthy model to try to find cell death inhibitors. To 
investigate the role of autophagy in the photoreceptor cell death, wild-type retinas were 
treated at the same time with A23187 in the absence or the presence of protease, using 
calpain inhibitor (ALLN) or cathepsin inhibitors (E64-d or L/P).   
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Figure 4.24 Calpain and cathepsin inhibition rescued from the A23187-induced cell death. (A) TUNEL 
staining in wild-type cultured retinas after 24 hours of A23187 in the presence or absence of calpain inhibitor 
(ALLN), cathepsin B, L and H inhibitor (E64-d) and the combination of cathepsin inhibitors (Leupeptin A 
and Pepstatin A).  (B) Quantification of TUNEL-positive cells. Mean ± SEM of three independent 
experiments is shown. (** p<0.001 to the control; ## p<0,001 referred to the vehicle of A23187). 
 
Interestingly, after 24 hours of treatment with A23187 in presence of protease and calpain 
inhibitors, the level of cell death was rescue in comparison with the same treatment in the 
absence of protease or calpains inhibitors (Figure 4.24A and 4.24B). Similarly, wild-type 
retinas were treated in combination with A23187, the autophagy inductor rapamycin, in 
combination with protease inhibitor; and the autophagy inhibitor wortmanin. Staining of 
TUNEL positive cells was carried out after 24 hours of treatment of A23187 in presence or 
absence of rapamycin or wortmanin. 
 
 
Figure 4.25. Autophagy modulation after A23187-induced cell death. (A) TUNEL staining of wild-type 
retinas after 24 hours of treatment with A23187, rapamycin, rapamycin, Leupeptin A and Pepstatin A, and 
wortmanin. (B) Quantification of TUNEL positive cells for the treatment of A23187 and rapamycin 
combination. (C) Quantification of TUNEL positive cells after 24 hours of treatment of A23187 and 
wortmanin. Mean ± SEM represented.  
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Remarkably, autophagy induction was detrimental in the A23187-treated model. The 
activation of autophagy with rapamycin in the A23187 model was increasing the 
photoreceptor cell death (figure 4.25A and 4.25B). More interestingly, the presence of 
protease inhibitors (Leupeptin A and Pepstatin A) was able to prevent the induction of cell 
death after rapamycin and A23187 treatment (figure 4.25B). Whereas, inhibition of 
autophagy with wortmanin was rescuing from the cell death induced by A23187 (figure 
4.25C). 
 
Together, these data suggest that increasing autophagy by rapamycin treatment in the 
A23187 model was increasing cell death levels. However, autophagy blockade by using 
wortmanin was decreasing cell death levels. Additionally, the increase in cell death with 
rapamycin was block by using cathepsin inhibitors (L/P). 
 
4.1.6 Autophagy induction increase photoreceptor cell death 
 
4.1.6.1 Autophagy induction by rapamycin 
Due to the results observed in the modulation of autophagy in the A23187-treated wild-
type retinas, Rd10 retinas were treated in vivo with rapamycin. For that aim, animals from 
postnatal day P13 were injected with intraperitoneal injections for 7 days with rapamycin 
(10 mg/kg). When the animals were at postnatal day P23, they were sacrificed, retinas 
isolated and TUNEL reaction was done.  
 
Figure 4.26. Autophagy activation increased TUNEL in Rd10 retinas. (A) TUNEL staining of Rd10 
retinas after 10 days of rapamycin treatment. (B) Quantification of the percent of TUNEL positive cells. 
Mean ± SEM represented. (* p <0.05). 
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Interestingly, autophagy induction with rapamycin treatment was increasing the cell death 
in the Rd10 mouse model (figure 4.26A and 4.26B). To avoid the response due to the 
inhibition of mTOR with the rapamycin treatment, Rd10 animals were injected 
intravitreously with trehalose, an mTOR-independent autophagy inductor. Sucrose was 
injected as control. For that experiment, Rd10 animals from postnatal day P20 were 
injected with trehalose and sacrificed at P22. Retinas were isolated and TUNEL reaction 
was carried out.  
 
Figure 4.27. Autophagy induction did not increased TUNEL, but increase ONL loss in Rd10 retinas. 
(A) Quantification of the percent of TUNEL positive cells. Mean ± SEM represented. (B) Representation of 
the percent of ONL loss in the retinas. Mean of every retina represented. (* p<0.05). 7 animals used in 2 
independent experiments. Contralateral eyes were treated with each drug.  
 
The percent of TUNEL was not rescue but the percent of the ONL loss was higher after the 
trehalose injections (figure 4.27A and 4.27B). In summary, Rd10 retinas were more 
sensible to the effects of autophagy induction and these effects were mTOR independent.  
 
4.1.6.2 Autophagy blockade with lysosomal inhibition treatment  
To address that the autophagy was being detrimental in the Rd10 retinas, autophagy 
inhibition was studied in the Rd10 mouse model. For that aim, intreavitreal injections with 
80 µM ALLN and 400 µM Leupeptin A and 40 µg/ml Pepstatin A were carried out.  
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Figure 4.28. Autophagy inhibition decreased cell death in Rd10 retinas. (A) TUNEL staining of Rd10 
retinas after Leupeptin A and Pepstatin A treatment. (B) Quantification of the percent of TUNEL positive 
cells. Mean ± SEM represented. (** p<0.01). 
  
Finally, Rd10 retinas presented an ameliorated phenotype after the ALLN and Leupeptin A 
and Pepstatin A treatment in vivo (Figure 4.28). In conclusion, these data suggest that 
blocking cathepsin activity was rescuing from photoreceptor cell death. We hypothethized 
that it is late for calpain inhibition to rescue cell death.  
  
 
4.1.7 HDAC inhibition as a new therapy for Retinitis pigmentosa 
 
4.1.7.1 Modulation of deacetylates: Trichostatin A 
The relation between histone deacetylases (HDAC) and autophagy is under current 
investigation (Li and Zhu, 2014). To address if the modulation and inhibition of 
deacetylases was affecting to the Rd10 photoreceptor cell death, viability of wild-type 
retinas after 24 hours of treatment with A23187 in presence or absence of the deacetylase 
inhibitor Trichostatin A (TSA) was studied. For that aim, TUNEL staining was done after 
the treatment and the TUNEL-positive cell was quantified. 
 
 
Results 
 
 89 
 
Figure 4.29 HDAC inhibition rescued from the A23187-induced cell death. (A) Representative confocal 
images from the ONL layer for TUNEL (green). Scale 50 µm. (B) Quantification of cell density of TUNEL 
positive cell. N=8 each condition, Student´s test (*** p<0.0001; # p<0.01). 
 
TSA treatment rescued from the A23187 induced cell death in wild-type retinas (figure 
4.29). So therefore, TSA was able to inhibit the cell induced by the calcium entrance to the 
photoreceptor. To solve if this rescue of the A23187-induced cell death was due to the 
modulation of autophagy, wild-type retinas after the combined treatment were studied by 
western blot technique.  
 
Figure 4.30 TSA do not restore the autophagy basal, neither autophagic flux levels after A23187-
induced cell death. Immunoblots from retinal extracts after 24 hours of A23187 in presence or absence of 
TSA. 
 
Interestingly, TSA was not triggering autophagy in the wild-type retinas. Indeed, TSA was 
decreasing the formation of LC3-II in wild-type retinas after proteases inhibitors (figure 
4.30). This result agreed with the improvement of the Rd10 retinas when autophagy flux 
was blocked. In addition, retinas from Rd10 animals at postnatal day P20 were treated with 
TSA for 24 hours. After the culture, retinas were fixed and TUNEL staining was carried 
out.  
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Figure 4.31 HDAC inhibition is rescuing from the photoreceptor cell death in Rd10 mouse model. (A) 
Representative confocal images from the ONL layer for TUNEL (green). Scale 50 µm. (B) Quantification of 
cell density of TUNEL positive cell. N=8 each condition, Student´s test (*** p<0.0001; # p<0.01). 
 
Interestingly, photoreceptor cell death was lower after the treatment with TSA (figure 
4.31). After these results, study of the mayor autophagy-related proteins was done. For that 
goal, Rd10 retinas of post-natal day P20 were treated with TSA for 24 hours and an 
immunoblotting was carried out from the retinal extracts. 
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Figure 4.32 Study of the basal autophagy and autophagy flux in Rd10 retinas after TSA treamtn. (A) 
Immunoblots from Rd10 retinal extracts after 24 hours of TSA. (B) Quantification of autophagy flux after the 
treatment with TSA. Autophagy flux was studied by dividing LC3-II/GADPH and then the sample with 
protease inhibitor divided by the control sample. (C) Study of the LC3-II protein levels after the treatment 
with TSA. Mean ± SEM of two independent experiments is shown. T-Student, * p-value < 0.05. 
 
After 24 hours of inhibition of HDAC in the Rd10 retinas, no changes in the autophagy-
related proteins was observed (figure 4.32A). Moreover, no differences were observed in 
the autophagy flux between vehicle and TSA treatment (figure 4.32B), and no differences 
in the LC3-II protein levels (figure 4.32C).  
 
Additionally, we treated the animals with TSA in vivo. Rd10 animals were injected 
intravitreously at postnatal day P20. Animals were sacrified at postnatal day P22 and 
retinas were isolated. After fixing, TUNEL reaction was done and images were taken with 
confocal microscopy. 
* 
* 
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Figure 4.33 HDAC inhibition do not rescue from cell death in Rd10 retinas. Rd10 animals were injected 
with TSA and vehicle. After two days, retinas were isolated. (A) Representative images of TUNEL staining 
from ONL layer of TUNEL (green) and nuclei (blue). Scale bar 50 µm. (B) Quantification of TUNEL 
positive cells. Nine animals each condition in total. 
 
No differences in the photoreceptor cell death were observed after the intravitreous 
injection with TSA (figure 4.33A and 4.33B). TSA was able to rescue in the explants ex 
vivo but no in the animals in vivo. This could be explained due to the difficulties of the 
intravitreous injections.  
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4.2 PHARMACOLOGICAL LYSOSOME-DEPENDENT CELL DEATH 
Due to the induction of cell death in the Rd10 mouse model photoreceptors when the 
animals were treated with rapamycin and trehalose, and the fact that autophagy was 
blocked before neurodegeneration, the molecular relation between autophagy and 
lysosomal damage was further studied. For that aim, lysosomal damage and lysosome-
dependent cell death was studied in vitro in autophagy-deficienct cell lines. Cationic 
amphiphilic drugs (CADs) were used as a model to trigger lysosomal damage and LMP. 
CAD treatment promotes the release of the acid sphingomyelinase (ASM) from the internal 
lysosomal membrane to the lysosomal lumen, inducing ASM degradation of the acid 
sphingomyelinase. This degradation sensitizes lysosomes to be more instable, inducing 
LMP (Petersen et al., 2013). 
 
4.2.1 Cationic amphiphilic drugs (CADs) as a model of lysosomal damage 
 
4.2.1.1 CADs induce cell death in mouse embryonic fibroblasts (MEFs) 
Several CADs were used to determine cell death in mouse embryonic fibroblast (MEFs). 
We used: desloratadine, ebastine, loratadine, siramesine and terfeneadine. The detergent 
Leu-Leu methyl ester hydrobromide (LLOMe) and hydrogen peroxide, t-butyl peroxide 
were used as positive controls for cell death. Cells were seeded in 96-well plates, the day 
after the cells were treated with the different compounds at the indicated doses and 
propidium iodide incorporation was assesed after 16 hours. The plate was run in Celigo 
machine and percent of propidium iodide positive cells was graphed. 
 
Figure 4.34. MEFs were used to evaluate cell death after CADs treatment. MEFs were seeded and 
treated for 16 hours with several CADs. Cells were stained with propidium iodide and Celigo analyze was 
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carried out. Four independent experiments were included in this graph. Deslor: desloratadine; Eba: ebastine; 
Lor: Loratadine; Sir: siramesine; Terf: terfenadine. T-Student. (** p-value<0.01; ***<p-value <0.001). 
 
Several antihistamines were able to induce cell death after 16 hours, such as ebastine 
15µM, siramesine 8µM, terfenadine 4µM and terfenadine 8µM (figure 4.34). Additionally, 
t-butyl peroxide 150µM was able to induce almost 50% of cell death. Interestingly, 
LLOMe was not able to induce cell death in MEFs after 16 hours. 
 
4.2.1.2 Tefernadine triggers lysosomal permeabilization in MEFs 
We selected terfenadine 8µM for subsequent studies as it induces moderate levels of cell 
death. To study the lysosomal damage leaded by terfenadine, galectin-3 
immunofluorescence was carried out as described by Dra. Jäättelä‘s group (Aits et al., 
2015). For that aim, MEFs were seeded in coverslips and treated with terfenadine 8 µM for 
3, 6, 18 and 24 hours. After that, immunofluorescence of galectin-3 was carried out. 
Percentage of cells with galectin-3 puncta was quantified and ploted.  
 
Figure 4.35. Terfenadine induces galectin-3 puncta in MEFs. (A) The graph represents the quantification 
of the percent of positive galectin-3 puncta cells. Three independent experiments. At least 200 cells per 
experiment were quantified. (B) Representative confocal images of galectin-3 immunofluorescence after 6 
hours of terfenadine treatment. Tef: terfenadine. T-Student test. * p-value<0.05. 
 
Quantification of galectin-3 puncta positive cells demonstrated a time-dependent response 
during terfenadine treatment. The staining with galectin-3 was higher in the first three 
hours of terfenadine treatment. Interestingly, this response decreased during long time of 
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terfenadine treatment (figure 4.35A). Representative images of galectin-3 are showed in 
figure 4.35B. Untreated cells present diffuse galectin-3 staining in the whole cytoplasm, 
while after 6 hours of terfenadine, galectin-3 was observed in bright puncta in the 
cytoplasm of cells.  
 
4.2.1.3 Terfenadine induces cathepsin B release in MEFs 
After LMP, cathepsin B can translocate to the cytoplasm and its diffuse staining can be 
used as a marker of LMP.  The percentage of diffuse cathepsin B (outside lysosomes) was 
studied after terfenadine treatment. MEFs were seeded in coverslips and treated with 
terfenadine 8 µM for 3, 6, 18 and 24 hours. After that, immunofluorescence of cathepsin B 
was carried out and the percentage of cells with diffuse cathepsin B was quantified.  
 
Figure 4.36. Terfenadine induces cathepsin B release in MEFs. (A) Percentage of cells with cathepsin B 
diffuse staining. The graph was done with three independent experiments. At least 200 cells per experiment 
were quantified. (B) Representative images of immunofluorescence of cathepsin B. In control condition, 
cathepsin B is observed in puncta (lysosomes) and the black hole of the nuclei can be observed; after 6 hours 
of terfenadine, most of cathepsin is observed in the whole cell, including nuclei. Tef: terfenadine. T-Student 
test. * p-value<0.05. 
 
As it is observed in figure 4.36A, terfenadine treatment induced cathepsin B release in 
80% of the cells after 6 hours. Moreover, 18 hours of terfenadine treatment showed a slight 
decrease in the percent of cells with cathepsin B release, but this percent increased after 24 
hours of terfenadine. This result could suggest that cells are trying to recover from the 
cathepsin B release after terfenadine treatment. It could indicate that there are two waves 
of lysosomal damage. Moreover, cathepsin B can be observed in puncta in the control 
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cells, while the cells treated with terfenadine for 6 hours presented diffuse cathepsin B 
(figure 4.36B). This results demonstrate that terfenadine induce cathepsin B release, 
indicating lysosomal damage and LMP.  
 
4.2.1.4 Terfenadine induces cell death in MEFs 
In addition, quantification of nuclei was carried out to detect the effect of terfenadine 
treatment in cell viability. The same approach as section 4.2.1.1 and 4.2.1.2 was carried 
out. After the treatment, cells were stained with DAPI and number of rounded and non-
fragmented nuclei was quantified.  
 
Figure 4.37. Terfenadine treatment induced cell death in MEFs. (A) Number of rounded nuclei per field. 
The graph was done with three independent experiments. At least 200 cells per experiment were quantified. 
(B) Representative images of DAPI in control condition and after 24 hours of terfenadine treatment. Tef: 
terfenadine. T-Student test. * p-value<0.05. 
 
As it is observed in figure 4.37A, terfenadine treatment induced a decrease in the number 
of nuclei per field. This decline began after 3 hours of treatment and it diminished with 
time. After 24 hours of treatment, nuclei lost their contour and chromatin appeared 
fragmented, indicating instable chromatin in MEFs (figure 4.37B). 
 
 
4.2.2 Autophagy-deficiency cell lines present lower lysosomal damage 
 
4.2.2.1 MEFs Atg7-/- are more resistant after CAD treatment 
After the develop of the techniques to study LMP in MEFs, the role of autophagy was 
studied after lysosomal damage with CAD treatment. For that aim, MEFs Atg7+/+ and 
Atg7 -/- were used to study viability after CAD treatment. First of all, we studied the 
autophagy induction after terfenadine treatment, to observe autophagy blockade in the 
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MEFs Atg7-/- and the accumulation of LC3-II due to the terfenadine-induced lysosomal 
inactivation. 
 
Figure 4.38. MEFs Atg7-/- do not present LC3-II. Western blot of MEFs Atg7 +/+ and Atg7-/- after 1, 3 
and 6 hours of terfenadine.  
 
As it shown in the figure 4.38, MEFs Atg7-/- did not present LC3-II in control situation as 
after terfenadine treatment. Interestingly, MEFs Atg7-/- presented unprocessed LC3, which 
was observed between LC3-I and LC3-II. MEFs Atg7+/+ presented a decrease of LC3-II 
after 1 and 3 hours of terfenadine treatment, which could suggest that autophagosomes are 
being degraded. Interestingly, an increase of LC3-II after 6 hours of terfenadine was 
observed, indicating autophagy blockade after that time. Both cell lines presented a 
decrease in the phosphorylation of S6 after 3 and 6 hours of terfenadine, suggesting an 
induction of autophagy. In conclusion, MEFs Atg7 -/- were not able to induce autophagy 
and terfenadine was blocking autophagy in MEFs Atg7-/- after 3 hours. 
 
To study viability of MEFs cells after CAD treatment, 3000 cells per well were seeded in 
96-well plates. The day after, treatment was carried out and propidium iodide was added to 
the cells after the treatments. The percent of cells with positive propidium iodide staining 
was quantified by Celigo and graphed. 
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Figure 4.39. MEFs Atg7-/- are more resistant to CAD treatment. MEFs were seeded and treated for 16 
hours with the indicated doses of CADs. Cells were then stained with propidium iodide and Celigo analyze 
was carried out. Four independent experiments were included in this graph. Deslor: desloratadine; Eba: 
ebastine; Lor: Loratadine; Sir: siramesine; Terf: terfenadine. T-Student test. *** p-value<0.001. 
 
MEFs Atg7-/- presented higher viability after the treatment with ebastine 15µM, loratadine 
8µM, siramesine 8µM and terfenadine 4 and 8 µM than MEFs Atg7+/+ (figure 4.39). 
Interestingly, the response with t-butyl peroxide was similar between both cell lines, which 
suggested that the differences observed in other treatment were not due to autophagy.   
 
4.2.2.2 MEFs Atg7-/- presented less lysosomal damage  
Next, MEFs Atg7 -/- were treated with terfenadine 8µM to understand how autophagy 
deficiency impacts the lysosomal damage. For that aim, MEFs Atg7-/- cells were treated 
and analyzed for galectin-3 immunofluorescence.  
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Figure 4.40. MEFs Atg7 -/- present less galectin-3 puncta positive cells than MEFs Atg7 +/+. 
Quantification of the percent of positive galectin-3 puncta cells. Three independent experiments. At least 200 
cells per experiment were quantified. Terf: terfenadine. T-Student test. *, # p-value<0.05. #: refers to the 
comparation between MEFs Atg7+/+ and Atg7-/-. 
 
Interestingly, MEFs Atg7 -/- presented a low percent of galectin-3 puncta positive cells in 
all the treatments studied in comparison with MEFs Atg7 +/+ (figure 4.40). 
 
4.2.2.3 LMP and cathepsin B release in MEFs Atg7-/- 
Similarly to the experiments of section 4.2.1.3, MEFs Atg7 -/- were compared with the 
MEFs Atg7 +/+ to observed differences in cathepsin B staining. For that aim, both MEF 
cell lines were seeded, treated with terfenadine at different times and cathepsin B 
immunofluorescence was carried out. Coverslips were observed under microscope and 
percent of cells with diffuse cathepsin B was counted. 
 
Figure 4.41. MEFs Atg7-/- present less cathepsin B release than MEFs Atg7 +/+. Percent of cells with 
cathepsin B diffuse staining. The graph was done with three independent experiments. At least 200 cells per 
experiment were quantified. Terf: terfenadine. T-Student test. *, # p-value<0.05. #: refers to the comparation 
between MEFs Atg7+/+ and Atg7-/-. 
 
Surprinsinlgy, MEFs Atg7+/+ display lower percent of diffuse cathepsin B cells in 
comparison with MEFs Atg7-/- after 3 hours of terfenadine. At later time points, Atg7-/-
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deficient cells displayed reduced diffuse cathepsin B staining in comparision to wt cells. 
(figure 4.41). These results demonstrated that autophagy is implicated in the response of 
the cells against lysosomal damage, suggesting that autophagy is aggravating the situation 
after CAD treatment.  
 
4.2.2.4 Viability with nuclei quantification after CAD treatment in MEFs  
Finally, DAPI quantification was carried out after terfenadine treatment in MEFs Atg7 -/-. 
For that goal, same experiment as described in the appart 4.2.1.4 was carried out for the 
same hours. Nuclei quantification was completed.  
 
Figure 4.42. MEFs Atg7 -/- present delay cell death in comparison with MEFs Atg7 +/+. (A) 
Representative confocal images of nuclei after 6 and 18 hours of terfenadine treatment in MEFs Atg7 +/+ and 
Atg7 -/-. (B) Number of rounded nuclei per field. The graph was done with three independent experiments. 
At least 200 cells per experiment were quantified. Tef: terfenadine. T-Student test. *, # p-value<0.05. 
 
Remarkably, MEFs Atg7 -/- presented more nuclei per field in comparison with MEFs 
Atg7 +/+ (figure 4.42). However, MEFs Atg7-/- presented a decrease in the number of 
nuclei/ field after 18 hours of terfenadine treatment, suggesting that MEFs Atg7-/- 
presented delay cell death.  
 
4.2.2.5 Autophagy induction after terfenadine treatment 
Additionally, autophagy was studied in both MEF cell lines after 16 hours of terfenadine 
treatment. For that aim, MEFs Atg7+/+ and Atg7-/- were seeded in coverslips. The day 
after, the cells were treated with terfenadine 8 µM. After 16 hours, coverslips were fixed 
and immunofluorescence of LC3 was carried out. Pictures were taken at confocal 
microscopy.  
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Figure 4.43. Terfenadine induced LC3 puncta in MEFs. Representative confocal images from MEFs 
treated with terfenadine for 16 hours. Scale 25 µm. 
 
 
After 9 hours of terfenadine, MEFs Atg7+/+ presented LC3 puncta, suggesting autophagy 
activation (figure 4.43). Moreover, with the combined treatment of terfenadine and 
leupeptin, no increase of LC3 was observed, suggesting that terfenadine is activating 
autophagy but the autophagosomes are not being degraded. 
 
Figure 4.44. Terfenadine induced LC3 puncta in MEFs Atg7+/+, but not in MEFs Atg7-/-. 
Representative confocal images from MEFs treated with terfenadine for 16 hours. Scale 25 µm. 
 
After 16 hours of terfenadine, MEFs Atg7+/+ presented LC3 puncta, suggesting autophagy 
activation (figure 4.44). As it was expected, MEFs Atg7-/- did not present LC3 
accumulation due to the impossibility of autophagy induction due to the Atg7 deficiency.  
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4.2.2.6 Viability of cell lines deficient in MEFs Atg5-/- 
To gain insight on the cytoprotective effect of Atg7-deficience after lysosomal damage, 
other autophagy-deficient MEFs was studied. MEFs Atg5-/- were seeded and treated with 
the CADs to study lysosomal damage. After that, propidium iodide was added to the wells 
and the plates were studied by Celigo. Percent of propidium iodide positive cells was 
represented. 
 
Figure 4.45. MEFs Atg5 -/- present similar viability in comparison with Atg5 +/+ after CAD treatment. 
MEFs were seeded and treated for 16 hours with several CADs. Cells were stained with propidium iodide 
and Celigo analyze was carried out. Five independent experiments were included in this graph. Deslor: 
desloratadine; Eba: ebastine; Lor: Loratadine; Sir: siramesine; Terf: terfenadine. 
 
Surprisingly, the percentage of propidium iodide between MEFs Atg5+/+ and MEFs Atg5-
/- was similar after the lysosomal damage (figure 4.45). These results could suggest that 
Atg7 deficiency could have a novel cytoprotective role during lysosome-dependent cell 
death.  
 
Figure 4.46. MEFs Atg5 -/- present LTR staining as MEFs wild-type. MEFs were seeded and staing with 
LTR. Pictures of MEFs Atg7+/+, MEFs Atg7-/- and Mefs Atg5-/- were taken. Scale 10 µm. 
 
We decided to study lysosomal acidification in MEFs Atg5-/- to identify differences in 
lysosomal acification and localization. Interestingly, no differences were observed in 
comparison with MEFs wild-type (figure 4.46). But, interestingly, MEFs Atg7-/- presented 
an increase in the staining in comparison with the other two cell lines.  
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4.2.3 ATG7-deficient cell lines presented differences in lysosomal 
characteristics 
 
4.2.3.1 MEFs Atg7-/- present ultrastructural differences 
Ultrastructural studies of MEFs were carried out to observe lysosomes. For that aim, cells 
were seeded in 6-well plates. Cells were fixed and observation of cells was carried out.  
 
Figure 4.47. Electronic microscopy from MEFs Atg7 +/+ and Atg7 -/-. Magnification from the cytoplasm 
of both cell lines showing vacuoles.  
 
The electronic microscopy observation suggest that MEFs Atg7-/- presented several 
vacuoles with electro-dense particles (figure 4.47). Interestingly, these particles were not 
observed in MEFs Atg7+/+. 
 
4.2.3.2 MEFs Atg7-/- present diffent lysosomal characteristics 
To understand the possible role of Atg7 to induce cell death after CAD treatment, we first 
assessed lysosomal acidity staining the cells with lysotracker red in both MEFs Atg7 +/+ 
and MEFs Atg7 -/- under basal conditions. Moreover, lamp1 immunofluorescence was 
done to study lysosomal protein. 
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Figure 4.48. MEFs Atg7 -/- presented differential lysosomal characteristics. Lysotracker staining (A and 
B) and Lamp1 (C) immunofluorescence of MEFs Atg7 +/+ and Atg7 -/-.  Representative confocal images. A 
and C, scale 10 µm. B, scale 25 µm.  
 
Interestingly, lysosomes from MEFs Atg7 -/- appear to be closer to the nucleus. 
Additionally, lysotracker presented stronger staining in comparison with the MEFs 
Atg7+/+. More importantly, when lamp1 was studied in both cell lines, no differences 
were observed (figure 4.48).  
 
Then, lysotracker was studied after terfenadine treatment at different times in both cells 
lines. MEFs were seeded and treated with terfenadine 8 µM for 3, 6, 9, 18 and 24 hours. 
After those hours, lysotracker was added to the wells to stain the acidic lysosomes. 
Coverslips were fixed and cells were observed at confocal microscopy. For this approach, 
lysotracker was added to the well after terfenadine treatment.   
 
A 
B 
C 
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Figure 4.49. MEFs Atg7+/+ and Atg7-/- presented differential lysosomal pH after terfenadine 
treatment. MEFs were seeded and treated with terfenadine 8 µM for 3, 6, 9, 18 and 24 hours. After those 
hours, lysotracker was added to the wells to stain the acidic lysosomes. Representative images of three 
different experiments are shown.   
 
Remarkably, lysotracker staining was stronger in MEFs Atg7-/- during more time than in 
MEFs Atg7+/+, at least, 6 hours after the treatment (figure 4.49). Interestingly, MEFs 
Atg7+/+ cell line was able to present lysotracker 24 hours after the treatment, although the 
lysotracker was missed at shorter times of terfenadine treatment. This result promoted a 
novel question: whether the MEFs Atg7+/+ are able to induce lysosomal biogenesis after 
terfenadine treatment? To resolve this question, lysotracker was added at the beginning of 
terfenadine treatment. Additionally, lamp1 immunofluorescence was done in the same 
coverslips. With this experimental approach, the lysosomes that maintain the acidic pH 
would be there during the complete treatment, while the novel lysosomes would be 
observed in red in the previous experiment. Additionally, the novel lysosomes would be 
stained with Lamp1.  
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Figure 4.50. Lysosomal biogenesis in MEFs Atg7 +/+ after long time terfenadine treatment. (A) MEFs 
were seeded in coverslips. Lysotracker was added before the terfenadine treatment. After the different time 
points, coverslips were fixed and observed. (B) Lysotracker was added before terfenadine treatment. (C) 
After the corresponding time of terfenadine treatment, coverslips were fixed and immonufluorescence of 
lamp1 was carried out. Two independent experiments. Representative images.  
 
Interestingly, MEFs Atg7+/+ lost the acidity of lysosomes after 3 hours of terfenadine 
treatment when we stain lysosomes at the end of the treatment. Interestingly, after 24 
hours, the survival cells present LTR staining. When we stained the lysosomes at the 
beginning of the treatment, LTR disappeared after 9 hours in the MEFs Atg7+/+, meaning 
that the residual lysosomes lost their acidity or that they are broken (figure 4.50B). 
However, when we stain the coverslips with Lamp1, we can observe Lamp1 lysosomes in 
puncta after 18 hours of terfenadine (figure 4.50C). These results could suggest that 
lysosomal biogenesis is happening after terfenadine treatment. Interestingly, MEFs Atg7-/- 
do not present these novel lysosomes; suggesting that may Atg7 is crutial to induce 
lysosomal biogenesis. 
 
 
4.2.3.3 Genes expression after terfenadine treatment 
Due to the possible lysosomal biogenesis observed with the LTR staining, we decided to 
carry out a qPCR. For that aim, MEFs Atg7+/+ and Atg7-/- were seeded and treated with 
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terfenadine. Then, cells were stopped and RNA extracted at different points: 3, 6, 9, 16 and 
24 hours. RNA extraction and qPCR were carried out as described in the section 3.2.6. 
 
Figure 4.51. Gene expression of autophagy and lysosomes related proteins in MEFs Atg7 +/+ and Atg7 
-/- after terfenadine time-course. qPCR analyze after 0, 3, 6, 9, 16 (on) and 24 hours of terfenadine. Two 
independent experiments.  
 
As is shown in the figure 4.51, TFEB decreased the expression after terfenadine treatment. 
However, TFEB is a protein able to translocate to the nucleus when lysosomal biogenesis 
is needed. Nevertheless, lamp1 increased its expression after 9 hours of terfenadine in 
MEFs Atg7+/+, which could indicate an overexpression of the CLEAR genes. 
Interestingly, Maplc3b and Sqstm showed an increase in the MEFs Atg7-/- after 9 hours. In 
conclusion, MEFs Atg7+/+ could increase the lysosomal biogenesis, but further 
experiments need to be done to highlight whether TFEB is translocated to the nucleus.  
 
 
4.2.4 ATG7 as a protein implicated in cell death 
Due to these differences in viability after lysosomal damage, more cell lines were 
compared. For this aim, Hela and MCF7 were used to compare response after 
antihistamines treatment in Atg7-deficiency.  
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4.2.4.1 Viability of Hela ATG7CRISPr after CAD treatment 
Hela cell line was used to compare the response of Atg7 after lysosomal damage. For this 
aim, Hela wild-type, Hela CRISPr control and Atg7 CRIPSr cell lines were used. 
Characterization of these cell lines was carried out by a western blot to detect Atg7 levels 
and LC3 after autophagy induction by rapamycin and inhibition by concanamicin A. For 
the viability assay, same approach was carried out: 3000 cells per well were seeded in a 
96-well plate. Treatment was done the day after and Celigo was run after the propidium 
iodide staining.  
 
 
Figure 4.51. Hela Atg7 CRIPSr cells do not present higher viability response after CAD treatment. (A) 
Hela wild-type, Hela CRIPSr control and Atg7 CRIPSr were seeded and treated overnight with rapamycin 
and concanamicin A. Protein extraction was carried out and study of proteins by western blot was done. (B) 
Hela wild-type, Hela CRIPSr control and Atg7 CRIPSr were seeded and treated for 24 hours with several 
CADs. Cells were stained with propidium iodide and Celigo analyze was carried out. Three independent 
experiments were included in this graph. Eba: ebastine; Lor: Loratadine; Sir: siramesine; Terf: terfenadine. 
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First of all, Hela CRISPr was working correctly, due Atg7 was disappeared in the Hela 
Atg7 CRISPr cell line (figure 4.51). Additionally, no autophagy was induced after 
rapamycin or concanamicin treatment. However, HeLa cell lines presented similar 
resistance to the CAD treatment, except to ebastine 15 µM, so it was complicated to induce 
cell death and compare with the previous results with no triggering other pathways. 
Fascinatingly, the Atg7 CRISPr cell line presented even more cell death than Hela wild-
type after terfenadine treatment.  
 
4.2.4.2 Viability of MCF7 shRNA 
To confirm this result, same approach was carried out in the MCF7 cell line. Dr. Jäättelä’s 
laboratory gave us gently two clones Atg7-deficiency by shRNA done in MCF7 cell line. 
Parental MCF7 was used as control. First, western blot was carried out to determine the 
deficiency of Atg7. 
 
 
Figure 4.52.  Atg7 protein levels in parental and 
shAtg7 clones in MCF7 cell line. Western blot to 
study Atg7 in shRNA MCF7. Parental MCF7 was 
used as a control.  
 
After confirming the deficiency of Atg7 in the shAtg7 clones (figure 4.52), viability of 
parental MCF7 and shAtg7 clones was studied after CAD treatment. Due to the higher 
resistant of the MCF7 cell line to CAD treatment, cells were seeded and treated for 48 
hours. After the treatment, propidium iodide was added to the wells and the percent of cells 
propidium iodide positive was graphed. 
 
Figure 4.53. MCF7 shAtg7 present less cell death than parental MCF7 after 48 hours of CAD 
treatment. Parental MCF7 and shAtg7 were seeded and treated for 24 hours with several CADs. Cells were 
stained with propidium iodide and Celigo analyze was carried out. Three independent experiments were 
included in this graph. Eba: ebastine; Lor: Loratadine; Sir: siramesine; Terf: terfenadine. (* p-value <0.05).  
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Remarkably, both clones of Atg7 presented lower cell death response after ebastine, 
siramesine and terfenadine treatment (figure 4.53). Additionally, the cell death rate was 
similar after hydrogen peroxide, but not after t-butyl peroxide. These results, with the 
results from the MEFs, suggest that Atg7 is aggravating the cell survival response after 
lysosomal damage. 
 
4.2.4.3 Reintroduction of ATG7 in the ATG7-deficient cell lines 
To demonstrate that Atg7 could present a novel role in lysosome-dependent cell death, we 
decided to reintroduce Atg7 in the Atg7-deficient cell lines. For that aim, Atg7-GFP was 
transfected to the shAtg7 clones of MCF7. First, the concentration of the plasmid was set 
up. After that study, the viability assay was carried out in both clones. For that aim, 
transfection was carried out and after 48 hours, cells were seeded and treated with the 
lysosomal damage inductors. GFP plasmid was used as a control. 
 
Figure 4.54. Western blot after the transfection of Atg7-GFP and GFP. Transfection of Atg7-GFP was 
detected by western blotting.  
 
The transfection of 0.5 µg of DNA was enough to not affect cellular viability and to have 
protein levels quite similar to the endogenous Atg7 (figure 4.54). After the detection of 
Atg7 transfection, we decided to transfect the cells for 48 hours and then proceed to do the 
viability assay with ebastine 15 µM and terfenadine 8 µM for other 48 hours. 
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Figure 4.55. Reintroduce Atg7 was able to rescue the phenotype in the clon 5 after terfenadine 
treatment. (A) Viability assay by celigo of parental MCF7 with GFP, and shAtg7 clon 5 with GFP and 
Atg7-GFP transfection after 48 hours CAD treatment. (B) Viability assay by celigo of parental MCF7 with 
GFP, and shAtg7 clon 1 with GFP and Atg7-GFP transfection after 48 hours CAD treatment. Three 
independent experiments were carried out. (* p-value <0.05). 
 
The viability in the clon 5 after the transfection and the CAD treatment showed that we 
were able to rescue the phenotype after terfenadine treatment. Additionally, an increase in 
the cell death was observed after the ebastine treatment in the Atg7-GFP transfected cells 
(figure 4.55A). However, the results obtained after the transfection in the clon 1 were 
different. There were no differences between the cells transfected with GFP or with Atg7-
GFP in any of the treatments (figure 4.55B).  
 
 4.2.5 Lipidomic studies in MCF7 cell line 
Due to the differences in lysosomal characteristics observed in MEFs Atg7+/+ and MEFs 
Atg7-/-, we decided to study lipids, due to the response of the cell after CAD treatment and 
the relation with the lipids change in lysosomes. 
 
Study of lipidomic profile was carried out in MCF7 cells. For that aim, cells were counted 
and lipids were extracted as in the appart 3.2.8. After the lipid extraction, lipidomic facility 
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from Danish Cancer Society Research Center was in charge of the study of the lipids. 
Three individual experiments with duplicate extractions were done for every cell line.  
 
Figure 4.56. Lipidomic profile of all the lipids species. Data is representative of three independent 
experiments with duplicates.  
 
Interestingly, the lipidic profile is different between Atg7-deficient and MCF7 parental cell 
line (figure 4.56). We decided to focus on sphingomyelin and ceramide, two types of 
lipids well-known to participate in lysosomal stability. 
 
 
Figure 4.57. Sphingomyelin species in parental MCF7 and shAtg7 clones. Two independent experiments.  
 
More interestingly, differences in sphingomyelinase species (SM) were observed between 
the parental cell line and both Atg7 knock-down clones (figure 4.57), for example, both 
clones presented less amount of SM 32:1;2, 34;1;2 or 42:2;2 in comparison with the 
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parental cell line. This result could suggest that the shAtg7 cell lines were more resistant 
due to the less amount of SM that the cells present by themselves.  
 
 
Figure 4.58. Ceramide species in parental MCF7 and shAtg7 clones. Two independent experiments.  
 
The ASM is in charge of modifying SM to synthetize ceramide. Ceramide was studied 
carefully due to the differences in the SM species levels (figure 4.58). The lipidomic study 
demonstrated that ceramide levels were higher in certain species, such as Cer 34;0;2, Cer 
40:1;2, Cer 44:1;2. Further investigation needs to be done to understand whether this 
lipidic imbalance is the mechanism which could explain the resistance of the Atg7-
deficient cell lines. 
 
 
 
 
 
 
 
 
 
 115 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 116 
 
 
 
 
DISCUSSION 
  117 
Discussion  
 
 118 
5. DISCUSSION 
5.1 RD10 MOUSE RETINA DISPLAYS A BLOCK IN AUTOPHAGIC FLUX 
 
Several experiments in this thesis aimed to elucidate autophagic processes in a 
mouse model of Retinitis pigmentosa. These experiments demonstrated that the Rd10 
retinas display lower LC3 and Ambra1 levels by immunofluorescence. In addition, our 
data show that the rd10 mice present less lipidated form of the autophagosomal marker 
LC3-II than the wild-type mice before neurodegeneration. The fact that most 
photoreceptors have been lost by P60 in the Rd10 retinas, and that the levels of LC3-II 
were almost imperceptible at this stage, could indicate that most of the autophagy activity 
comes from photoreceptors. Also he phosphorylation of S6 was observed in the western 
blot, according to the fact that autophagy is blocked in the Rd10 retinas. Moreover, when 
we blocked the autophagy flux by using lysosomal inhibitors, no increase of LC3-II was 
observed in the Rd10 retinas. As the levels of the protein p62 were increased in the basal 
stage in the Rd10 retinas, these data confirm the existence of an autophagy block in the 
rd10 retina.  
 
Interestingly, when we treated the Rd10 mice with rapamycin in vivo or using the 
mTOR independent activator trehalose, photoreceptor cell death was increased in the 
retina. More importantly, downregulation of autophagy by using leupeptin and pepstatin A 
rescued form the photoreceptor cell death. This entire batch of experiments demonstrated 
that autophagy was detrimental in the Rd10 retinas. Several studies demonstrated that 
autophagy was detrimental in other models of retinal disease. This was observed, for 
example, in another model of retinitis pigmentosa caused by the mutation P23H in the 
opsin gene that induce conformational alterations of the protein that results in 
photoreceptor degeneration (Bogea et al., 2015). In 2015, a group used one model of 
Xenopus laevis, where the tadpoles express the bovine mutated P23H opsin in 
photoreceptors. When these tadpoles were exposed to 12 hours of light and 12 hours of 
dark, they displayed autophagy induction and photoreceptor cell death. The authors 
proposed that autophagy was implicated in the photoreceptor cell death, but they did not 
demonstrate an increase of autophagosomes or autophagy flux when they administrated the 
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photoreceptor cell death inductor AP20187 to the animals (Bogea et al., 2015). In retinal 
for example, in 2007, a study demonstrated that autophagy was only present in degenerated 
photoreceptor (Kunchithapautham and Rohrer, 2007). 
 
Detrimental autophagy is also found in other tissues, not only in retina. In cortical 
neurons, after deprivation of glucose and reintroduction of glucose, the authors 
demonstrated that during the reintroduction, calpains are activated, leading to LMP and 
cell death. They proposed that during the glucose reintroduction, autophagy changes from 
an adaptive process to a defective autophagy pathway, which contributes to neuronal death 
(Gerónimo-Olvera et al., 2017). On the other hand, several studies have demonstrated that 
autophagy is beneficial in retinal neurodegeneration. In 2011, Kunchithapautham and 
colleagues demonstrated that rapamycin protected photoreceptors after light damage in 
Balb and GFP-LC3 mice as the consequence of autophagy induction in cones 
(Kunchithapautham et al., 2011). Others authors demonstrated that treating the 661w cell 
line with rapamycin after light damage was increasing cell viability (Li et al., 2014).  
Moreover, in Kaushal’s thesis (Kaushal, 2006) the expression of the mutated P23H opsin 
in HEK293 cells was inducing autophagy, and this effect was stronger after rapamycin or 
amino acid depletion. Aggregates of P23H were being degraded specifically after 
autophagy induction. In summary, they concluded that autophagy was beneficial in this 
model (Kaushal, 2006). In conclusion, it seems that increasing autophagy appears to be 
cytoprotective in models that are associated to accumulation of misfolded proteins.  
 
Autophagy is also detrimental in other models of degeneration. For example, during 
ischemic reperfusion, several tissues, such as cardiac muscle (Ma et al., 2015), liver 
(Cursio et al., 2015) or cerebral neurons (Zhang et al., 2013) enhance autophagy after 
ischemic reperfusion, but the role of autophagy remains still under debate. Studies in 
autophagy-deficient models have been used to understand the role of autophagy in retina. 
For example, the Atg5 (flox/flox) Nestina-cre is a mouse model of Atg5 deficiency in the 
neuronal precursors. This model presents photoreceptor degeneration. Interesintlgy, 
authopagy deficiency leads to an increase in CMA, indicating a cross-talk between both 
catabolic pathways during retinal degeneration (Rodríguez-Muela et al., 2013). 
Furthermore, after optic nerve axotomy, a model of glaucoma, which promotes the cell 
death of retinal ganglion cells, the Atg5 (flox/flox) or Atg4B knockout mouse models 
present less survival of the ganglion cells, while autophagy induction increases the numer 
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of surviving cells (Rodriguez-Muela et al., 2012). Additionally, other study demonstrated 
that animals Atg5ARPE and Atg7ARPE, which are animals deficient in Atg5 or Atg7 in the 
RPE specifically, presented a reduction of the photoreceptor layer (Zhang et al., 2017). All 
these data together demonstrate the importance of autophagy in the retina and more 
specifically, in photoreceptors, but why under some conditions autophagy is detrimental or 
beneficial needs to be further elucidated. 
 
With the batch of data from this thesis, we concluded that autophagy was 
detrimental in the Rd10 mouse model. Several models commented previously present 
autophagy as a cytoprotective mechanism in models with protein accumulation. 
Interestingly, when we block lysosomal function, we observed an increase in the survival 
cells. It seems that increased autophagy is deleterious when lysosomal damage in involved; 
on the other hand, when the cells present proteic aggregates, increased autophagy could 
help to the survival of the cells, suggesting a dual role for autophagy in the retinal 
homeostasis. 
 
5. 2 THE RD10 MOUSE MODEL DISPLAY LYSOSOMAL MEMBRANE 
PERMEABILIZATION 
 
The Rd10 mouse model presents a deficiency in the phosphodisterase Pde6b. As 
described in the introduction, this mutation leads to a calcium increase inside the cells. A 
calcium input in the cells can have several implications, such as triggering calpain 
activation (Sahara and Yamashima, 2010); In this thesis, we have analysed the relation 
between calpains and photoreceptor cell death, which has been described previously in 
other mouse models of Retinitis pigmentosa (Sancho-Pelluz et al., 2008; Łopatniuk and 
Witkowski, 2011). We demonstrated that calpain-2 (also known as m-calpain) appeared in 
the cleaved form from postnatal day P15 to postnatal day P25. Conversely calpain-1 (also 
known as µ-calpain) is not cleaved in this model. 
 
As calpains have been implicated in lysosomal membrane destabilization and 
autophagy blockade (reviewed in Serrano-Puebla and Boya, 2016; Serrano-Puebla and 
Boya, 2018), we decided to study lysosomal integrity in the Rd10 retinas. First of all, our 
experiments demonstrated that cathepsin B and Lamp1 were not colocalizing in the 
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lysosomes, suggesting the release of cathepsin B outside lysosomes. Additionally, the 
retinas were stained with the fluorogenic Cathepsin B substrated called Magic Red. This 
staining appeared in photoreceptor cytoplasms in the rd10 retinas, but it is restricted in 
lysosomes in the wild type retinas. These results demonstrated that the Rd10 retinas 
present cathepsin B activity in the whole photoreceptor cytoplasm. These experiments 
suggested that Rd10 retinas presented an increase of calcium – caused by the mutation-, 
leading to calpain activation and LMP.  
 
Several publications have demonstrated the relation between calpains and 
lysosomal membrane destabilization. In the first place, in an in vitro model in rat brain 
demonstrated that calpain-1 is able to cleave Lamp2, a lysosomal membrane protein 
essential for the lysosomal stability (Villapando and Torriglia, 2014). In the second place, 
during the mammary gland involution, calpain activation has been related to lysosomal 
destabilization (Kreuzaler e tal., 2011). Finally, some other authors proposed that calpains 
can present a role during LMP (Luke and Silverman, 2010; Kreuzaler et al., 2011). Further 
experiments should be done to analyze if calpains are implicated in the lysosomal damage 
in that model. During retinal degeneration in a rat model of P23H RHO, researchers 
discovered that calpain-1 and 2 were not overexpressed, but they found increased levels of  
caspase-12 protein compared to the wild-type animals. Interestingly, they observed an 
increase in the expression of apoptotic-related proteins, such as Bax, Bcl2 or Puma. In 
addition, they demonstrated mTOR inhibition in the P23H rats with rapamycin injections 
increased the visual function (Sizova et al., 2014). Interestingly, this model presented an 
increase in calpains in photoreceptors but, in this case, the autophagy induction increased 
cell viability. One of the differences between this model and Rd10 is the increase of 
apoptotic proteins. In our laboratory, we did not observe induction of apoptotic proteins in 
the Rd10 retinas (data not shown). It would be interesting to elucidate if autophagy is 
detrimental or beneficial depending on the apoptosis activation. 
 
The relation between autophagy and LMP needs to be understood. Most of the 
studies demonstrate an autophagy block when lysosomes are damaged, for example in 
lysosomal storage disorders (LSD) (Settembre et al., 2008; Gabandé-Rodríguez et al., 
2014), in neurodegenerative diseases, as in Alzheimer’s Disease (Vila et al., 2011) or 
under administration of certain chemotherapies (Kanzawa et al., 2004). Interestingly, we 
observed that autophagy is blocked at P16 but we observed LMP at P20. It is really 
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important to understand why autophagy is blocked before LMP induction. More 
interestingly, autophagy was detrimental in the photoreceptor survival when we triggered it 
with rapamycin or trehalose. LMP has been shown to induce autophagy blockade in a wide 
range of diseases, such as in pancreatic cancer (Liu et al., 2017), Parkinson disease (Bové 
et al., 2014) or renal injuries (Song et al., 2017). In conclusion, we hypothesize that 
autophagy was increasing the damage triggered by LMP.  
 
Understanding the circumstances that activate LMP are necessary to try to find 
ways to block them. For example, iron chelation can attenuate LMP and cell death in vitro 
(Berndt et al., 2010). Another strategy to protect cells from LMP is the overexpression of 
Hsp70 (Kirkegaard et al., 2010). For example, N-Methyl-N-nitrosourea (MNU) toxicity, an 
in vitro model of photoreceptor cell death, present a less harmful phenotype when the 
animals are treated with valproic acid, which induces Hsp70 expression (Mitton et al., 
2014). Hsp70 is a chaperone that connects with Lamp2A to stabilize lysosomes 
(Bandyopadhyay et al., 2008). Interestingly, Lamp2A is a protein which is increased in the 
Rd10 retinas, suggesting an attemp to ameliorate lysosomal function. 
 
Moreover, LMP has been related to apoptosis. Both pathways are quite related, but 
we did not observe caspase activation in the photoreceptors (data not shown). After all of 
these experiments, we wondered the mechanism how photoreceptors are dying in the Rd10 
mouse model. Due to the fact that there is no caspase activity in the Rd10 mouse model 
and the LMP was confirmed with the experiments from this thesis, we hypothesize that 
lysosome-dependent cell death is happening in the photoreceptors of the Rd10 mice. This 
model could be a model to study the direction of lysosome-dependent cell death with no 
relation with caspase-dependent apoptosis. 
 
 
5. 3 CIRCADIAN VARIATION OF AUTOPHAGY IN RETINA 
 
We had some difficulties to conclude some of the experiments related to study 
autophagy due to the variability observed in the levels of LC3-II. In 2014, Yao and 
colleagues (Yao et al., 2014) demonstrated that autophagy oscillate throughout the day and 
it is quite related to the circadian cycle. For example, 1 hour after the shift from light to 
dark or from dark to light, there was a decrease in the LC3-II/LC3-I ratio. After 
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understanding the point that autophagy is changing almost every hour in the retina, we 
decided to sacrifice the animals for experiments always at the same hour.   
 
The link between circadian rhythm and autophagy has been demonstrated in more 
neuronal models, besides retina. For example, in hippocampus, autophagy proteins appear 
decreased during sleep fragmentation (He et al., 2016). Moreover, in brain, melatonin, the 
hormone released during sleeping time, activates autophagy to delay ageing phenotype 
(Jenwitheesuk et al., 2014). Also, several studies demonstrated that the loss of circadian 
rhythm leads to an increase in the incidences of several diseases, such as Alzheimer and 
Parkinson, suggesting the possible relation between resting and autophagy. In these cases, 
autophagy regulation plays an important role to ameliorate the diseases (Maiese, 2017). 
This effect has been observed in other tissues, not only neuronal. In liver, it has been 
demonstrated that autophagy has a role in glucose metabolism during diurnal hours (Li and 
Lin, 2015). Additionally, it has been demonstrated that Atg14 is playing an essential role in 
lipid metabolism in pancreas, according to the circadian rhythm (Xiong et al., 2012). In 
conclusion, all of these novel finding suggest the relation and importance of autophagy and 
circadian rhythm. 
 
 
5.4 THE DEACETYLASE INHIBITOR TRICHOSTATIN A RESCUES FROM 
THE RD10 RETINA CELL DEATH 
 
HDAC classes I/II seems to precede photoreceptor degeneration in the rd1 model 
(Sancho-Pelluz et al., 2010). Furthermore, other studies have reported that some HDACs 
are implicated in autophagy process (Iwata et al., 2005; Lee et al., 2008). Thus, we decided 
to study Rd10 photoreceptor degeneration after treatment with HDAC inhibitor TSA. Our 
results show that in vitro model with the calcium ionophore A23187 presented lower cell 
death rate after treatment with TSA. In addition, treatment with TSA rescued Rd10 
photoreceptor cell death ex vivo, but this was not observed in vivo. In addition, previous 
studies show the rescue in rd1 mouse model inhibiting HDAC (Sancho-Pelluz and Paquet-
Durand, 2012). The authors of this research proposed a model: the elevated calcium 
accumulation causes HDAC overactivation, which could reduce transcription factor CREB 
activity, implicated in reactive oxidative species (ROS) protection. These ROS could cause 
DNA damage and therefore activation of PARP; with subsequent energy depletion and 
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translocation of apoptosis factors to the nucleus. This hypothesis could explain the rescue 
with the treatment of TSA in Rd1 mouse model as well as in the Rd10.  Although we have 
observed rescue with TSA in both models, the Rd10 and wild-type retinas treated with 
A23187, we have not observed a significant rescue in Rd10 treatment in vivo. One 
explanation could be the difficult of the intravitreous injections, due to the small size of the 
mice eyes. Anyway, as a tendency was also observed in vivo, further experiments will 
clarify whether TSA could be a cytoprotetive agent in the retinitis pigmentosa mouse 
models in vivo.  
 
However, in vitro experiments show contradictory results in cell viability after 
HDAC inhibition. For example, in bladder cancer cells induces cell death via intrinsic 
apoptosis (Wang et al., 2017), in lung cancer cells TSA induces cell death through Akt 
inhibition (Yang et al., 2017). In 2003 a study demonstrated that HDACs induce cell death 
act via death receptor pathway (extrinsic) or mitochondrial pathway (intrinsic) to activate 
caspases (Rosato et al., 2003). For instance, HDAC inhibition protect against the pyruvate 
dehydrogenase dysfunction in Huntington's Disease (Naia et al., 2017); moreover, other 
studies reported that treatment of cerebellar granule neurons with HDAC inhibitors induce 
apoptosis (Morrison et al., 2006). The opposite effects of HDAC inhibition could be 
explained by the tissue and stage-specific expression of different classes of HDAC. 
Finally, taking into account the importance of HDAC6 in autophagosomes degradation 
(Iwata et al., 2005) and the implication of this protein in multiple neurodegenerative 
disorders (Du and Jiao, 2011), it would be interesting to test a specific HDAC6 inhibitor in 
the Rd10 retinas and support the importance of autophagy fas a new therapeutic target for 
Retinitis pigmentosa. 
 
To further investigate the role of autophagy in TSA rescue, autophagy flux was 
studied in retinas treated with A23187 and TSA. Although our results displayed a rescue of 
the cell death, there was no increase in autophagy flux. An autophagy block was observed, 
according to our previous hypothesis that autophagy is detrimental in the Rd10 model. As 
commented previously, autophagy inhibition appears to be beneficial for the photoreceptor 
survival in certain scenarios. Actually, in cultured rat cardiomiocytes, the HDAC inhibition 
with TSA results in the inhibition of cardiac hypertrophy by autophagy suppression (Cao et 
al., 2011). However, the activation of autophagy with HDACs inhibitors seems to be 
tissue-dependent. Fascinatingly, and contrary to our results, a study demonstrated that 
Discussion  
 
 125 
autophagy is enhanced by deacetylase inhibitors in a FOXO-dependent manner in MEFs 
(Zhang et al., 2015). Recently it has been demonstrated that TSA enhances autophagy after 
subarachnoid hemorrhage in rats and that  this induction ameliorates the phenotype (Shao 
et al., 2016). We observed an improvement of cell survival in the Rd10 retinas, but may 
due to the autophagy block that TSA induces in the retina. Interestingly, in a Parkinson 
model it has been demonstrated that HDAC inhibition potentiates the model of neuronal 
cell death. Interestingly, in this model, the inhibition of autophagy leads to improve the 
phenotype (Park et al., 2016). However, in cancer cell lines, it has been demonstrated that 
TSA is able to induce cell death through with ROS increase (Sun et al., 2014). 
 
In order to conclude the implication and importance of autophagy in retinal 
dytrofies and, in particular, in the Rd10 mouse model, further studies need to be 
performed.  
 
 
5.5 THE TREATMENT WITH CADs INDUCES LYSOSOMAL DAMAGE AND 
CELL DEATH IN MOUSE EMBRYONIC FIBROBLASTS 
 
In the second part of this thesis, we have tried to understand the processes triggered 
by lysosomal damage, LMP and lysosome-dependent cell death and their relation with 
autophagy. MEFs were used to study these links at molecular level. Several lysosomal 
damage agents were used in this thesis: anti-histamines with CAD properties; LLOMe as a 
detergent; and the ROS inducers, hydrogen peroxide and t-butyl-peroxide. Our results 
showed that two of the anti-histamine drugs were inducing cell death in MEFs: ebastine 
and terfenadine, but no cell death was observed after loratadine and desloratadine. 
Curiously, siramesine was not inducing significant levels of cell death; however, t-butyl-
peroxide was inducing cell death in MEFs. The differences observed between the different 
lysosomal damage inductors represent the complexity of LMP; every LMP inductors 
induce different cascade of signaling to –maybe- induce cell death. Siramesine was not 
able to induce cell death in our system, but previously, siramesine was described as 
lysosomal damage inductor able to trigger cell death through caspase-independent pathway 
in MCF7 cells (Ostenfeld et al., 2005), but we were not able to reproduce this results in our 
system. However, the processes triggered by siramesine are not completely elucidated yet. 
Interestingly, a recent publication demonstrated that siramesine induces cell death first 
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through mitochondrial membrane permeabilization (MMP), which triggers LMP 
afterwards (Česen et al., 2013). More experiments should be done in our model to 
understand why cell death is not triggered in MEFs after siramesine treatment.   LLOMe is 
a detergent that induces LMP, but requires cathepsin C to be active (Jacobson et al., 2013). 
The fact that the cells lines used in this thesis do not have big amount of cathepsin C could 
be a reason why LLOMe is neither inducing cell death, nor galectin-3 puncta (data not 
shown). However, it has been described recently that Hela cells die after LLOMe treatment 
through proteolytic signaling. The authors hypothetized that the reason is the absence of  
cathepsin B or L in the cytosol (Repnik et al., 2017). In our system, his could be an 
explanation why we did not observe cathepsin B release in our model (data not shown), but 
this do not explain why we did not observe galectin-3 after LLOMe in MEFs. 
 
The mechanisms of action of the anti-histamines are poorly understood to date. It 
has been described that most of them induce cell death through lysosomal destabilization 
in cancer cell lines, such as non-small cell lung cancer cell lines, prostate cancer cell line 
and breast cancer (Ellegard et al., 2016). More interestingly, the authors demonstrated that 
loratadine and astemizole had a low effect in cell death in vitro, but in a clinical trial with 
patients with lung cancer treated with these two anti-histamines, they presented the lowest 
mortality in comparison with patients administred other anti-histamines more effective in 
vitro. The authors proposed that the tissue distribution of loratadine and astemizole is 
higher comparing with others anti-histamines, such as terfenadine, which is a potent killer, 
but may present less efficient tissue distribution. These data demonstrated the specificity 
and differences of action between every CAD. 
 
Our results demonstrated that MEFs Atg7-/- display decreased cell death after 
CADs treatment. As commented in the introduction, autophagy-dependent cell death 
(ADCD) and lysosomal-dependent cell death (LDCD) are processes highly related which 
difficult the differentiation from one type of cell death to other. We wondered whether 
(ADCD) could be occuring in MEFs Atg7+/+ after CAD treament. ADCD and lysosome-
dependent cell death are two processes highly related. Some authors proposed that ADCD 
is characterized by an enhanced autophagic flux (Fulda and Kögel, 2015; Mariño et al., 
2014). The circumstances when autophagy inhibitors do not block cell death, although an 
increase of LC3 or p62 decrease is visible, should not be considered ADCD. In our studies, 
we did not observe rescue from terfenadine-induced cell death after combined the 
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treatment with wortmanin. In the same way, the common condition for LDCD is the 
cathepsins release. Additionally, the use of cathepsin inhibitors should prevent the cell 
death. In fact, the cathepsin B inhibitor CA-074 can block most of the LDCD (Montaser et 
al., 2002). Furthermore, E64-d or z-VAD, a well-known apoptotic inhibitor that also 
inhibit the lysosomal cysteine cathepsins (Schote et al., 1999). In our model, autophagy is 
induced after one hour of terfenadine treatment due to the reduction of phospho-S6, but we 
concluded that at that point, autophagy flux was not efficient due to the fact that LC3-II 
was not increased after terfenadine treatment. However, our model display cathepsin 
release from lysosomes, but the treatment with cathepsin inhibitor, like E64d and Pepstatin 
A, was not blocking cell death (data not shown). To prevent the precise moment when 
cathepsin release is inducing cell death is quite complicated due to the differences in the 
dynamism of cathepsin release in both cell lines. We concluded that in our system it is 
LDCD (and not ADCD) what is happening during the cell death because we did not 
observe autophagy flux increase. Further experiments have to be done to try to rescue from 
terfenadine-induced cell death with cathepsin inhibitors.  
 
Lysosome-dependent cell death triggered after CAD is poorly understood. The 
experiments carried out to assess cathepsin B activity aimed to understand whether the 
cells presented LMP after the treatment with terfenadine. New questions appeared when 
we used MEFs Atg7-/-. The experiments presented two different responses between MEFs 
Atg7 +/+ and MEFs Atg7 -/-. At 3 hours, both cell lines presented similar percentage of 
cells with diffuse cathepsin B (close to 30%); but after 6 hours, MEFs Atg7 +/+ displayed 
an increase of the number of cells with diffuse cathepsin B (± 80 %), while MEFs Atg7-/- 
presented a reduction (± 20 %). This difference is observed at 16 hours. But, after 24 
hours, the effect was similar in Atg7-/- than wild-type MEFs. This experiment suggested 
that autophagy is contributing to lysosome-dependent cell death, at least at the early time 
points after CAD treatment.  
 
At what point are LDCD and ADCD interacting? It is not the first time that it is 
described that lysosomal damage is less detrimental in autophagy-deficient models. For 
example, the treatment with tetrahydrocannabinol (THC) in cancer cell lines is inducing 
cell death through endoplasmic reticulum stress, autophagy induction and LMP (Salazar et 
al., 2009; Hernández-Tiedra, et al., 2016). In this publication, the authors demonstrated 
that the genetic deficiency of Atg5 and Atg7 prevented from the THC-induced cell death.  
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In this thesis, we hypothesize that there are two waves of cathepsin B release due to 
the different responses between MEFs Atg7+/+ and Atg7-/- during the terfenadine time-
course. The first wave would need autophagy-related proteins to act. In fact, it has been 
demonstrated that Atg7 overexpression induced an increase in cathepsin B expression in 
INS-1 cells exposed to fatty acids (Li et al., 2013), triggering the proinflammatory and 
apoptotic response. This result shows the relation between autophagy-related proteins and 
cathepsin B. The second wave would be autophagy-independent, triggering the cell death 
pathway.  
 
Additionally, the experiments carried out with galectin-3 demonstrated that 
terfenadine is inducing galectin-3 puncta formation in MEFs after 3 hours of treatment. 
After 6 hours the number of cells with galectin-3 dots is almost the 70% in MEFs wild-
type, but after long-time treatment, such as 18 hours or 24 hours, the percent of cells with 
galectin-3 dots decreased. This protein can be used as a marker for LMP (Aits et al., 2015), 
but recently it has been described a novel function for galectin-3. Chauhan and colleagues 
proposed that TRIM family proteins interact with galectins to guide autophagy to target 
damaged lysosomal membranes after LLOMe treatment (Chauhan et al., 2016). This result 
proposes galectin protein family as lysophagy receptors (Maejima et al., 2013). 
Considering this point, galectin-3 could be a signal for damaged endolysosomal 
membranes, and not only for LMP. When MEFs Atg7-/- were treated with terfenadine in a 
time-course experiment and then the galectin-3 was studied, the percent of cells with 
galectin-3 dots was always lower in comparison with MEFs Atg7+/+. Considering the two 
possible options of galectin-3 staining, our experiments could suggest two things: firstly, 
MEFs Atg7-/- displayed reduced lysosome damage and LMP after terfenadine treatment; 
secondly, MEFs Atg7-/- do not trigger the receptors for lysophagy after this treatment, but 
it would be interesting to determine whether the lack of Atg proteins induces a fail in the 
receptors signaling. To discuss both options, we can study cathepsin B release after 
terfenadine treatment. After 3 hours of terfenadine treatment MEFs Atg7-/- presented more 
of cells with cathepsin B release than MEFs Atg7+/+. This result could suggest that 
lysosomal damage and LMP are happening in both cell lines, but Atg7 is not inducing 
galectin-3 signal as a lysophagy receptor. Additional experiments should be done to 
understand why Atg7 lack promotes defects in the autophagy-receptor signaling. 
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5.6 ATG7-DEFICIENT CELLS PRESENT A DECREASE IN LYSOSOMAL 
DAMAGE AND CELL DEATH 
 
In this thesis, it has been described the differences in viability between MEFs 
Atg7+/+ and MEFs Atg7-/-, being Atg7 deficiency a beneficial situation after lysosomal 
damage treatment. Additionally, two clones of shAtg7 MCF7 breast cancer cells were used 
to corroborate the hypothesis that Atg7 is inducing the cell death after CAD treatment. To 
test whether Atg7 could have a role related to lysosomal damage, Atg7 was reintroduced in 
MCF7 shAtg7. The rescue was observed in one of the clones after terfenadine and ebastine 
treatment, suggesting that Atg7 could present a role in lysosomal damage, but it may 
depend on the protein levels of every cell line. Surprisingly, HeLa ATG7 CRISPr did not 
present any differences in cell viability in comparison with HeLa wild-type. One 
explanation could be that whether autophagy is activated and is involved in LCDC. But 
this reason is not enough to explain the results. Firstly, because viability of MEFs Atg5-/- 
is similar to MEFs Atg5+/+ after CAD treatment. This result indicates that autophagy 
perse is not implicated in lysosome-dependent cell death. If autophagy would be 
implicated in cell death, Atg5-deficiency cell line would be also resistant to lysosomal 
damage induction. Second, because there is autophagy flux blockade after terfenadine 
treatment, suggesting that autophagosome-dependent cell death is not being induced. 
Additionally, the differences observed in MEFs Atg7-/-, such as the stronger LTR staining 
in comparison with MEFs Atg7+/+, or the differences observed in the lipid profile (that 
this book will discuss later), or the different dynamic for cathepsin B release, response 
found in MEFs Atg7-/- but not in MEFs Atg7 +/+, suggest that Atg7 has a role autophagy-
independent and related to lysosomes.  
 
As commented in the introduction, it is not the first time that autophagy-related 
proteins present novel autophagy-independent functions. In fact, Atg7 has been related to 
an increase in cell death after lysosomal damage previously. In 2012, Kessel and 
colleagues demonstrated that shRNA knock-down of Atg7 in murine hepatoma cell line 
lclc7 increased the resistance to photodamage, a classic lysosomal damage inductor 
(Kessel et al., 2012). This model induces caspase activation, which is suppressed in the 
Atg7-deficiency cells. Similar results were demonstrated in 2010, when Walls and 
colleagues demonstrated that cultured neural precursor cells treated with chloroquine or 
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bafilomycin A1 caused blockade of autophagic flux and apoptosis. An Atg7 knock-down 
suppressed the apoptosis induced by chloroquine and bafilomycin A1, compounds that 
affect to the lysosomal stability (Walls et al., 2010). These authors proposed that Atg7 is 
necessary for the p53 phosphorylation-induced after lysosomal damage. Further 
experiments should be done to extrapolate this model to the system presented in this thesis. 
 
Furthermore, another research demonstrated that Atg7 knock-down repressed the 
apoptosis induced by TGF-β in human hepatocarnoma cell line. In addition, the Atg7-
deficiency cell line was able to jump the cycle arrest induced by TGF-β. In conclusion, the 
authors proposed that autophagy inhibition in TGF-β-mediated cell death was attributable 
to the apoptosis induction and cell cycle arrest (Kiyono et al., 2009).	 Several other 
publications have demonstrated additional roles for Atg7 related to cell cycle and cell 
death (Xiong, 2015). For example, in 2012, Atg7 was described as necessary to survive 
during starvation due to its interaction with p53 in MEFs. This interaction promoted the 
expression of p21 during starvation. Atg7-deficient cells did not express p21, promoting a 
fail in the cell cycle arrest, thus increasing the damage DNA (Lee et al., 2011). This 
relation between Atg7 and p53 is quite important, due to the importance of p53 during cell 
cycle; and suggests that Atg7 is participating in cell cycle control. Additionally, it has been 
described that p53 is a protein which can trigger LMP. For example in myeloid leukemia 
cells, the activation of p53 can induce LMP (Yuan et al., 2002); other publication 
demonstrated that in fibrosarcoma cells, phosphorylated p53 translocates to the lysosomes 
through the interaction with a protein called LAPF, triggering apoptosis (Li et al., 2007). 
The mechanism of action of p53 in the lysosomal membrane remains unknown. It could be 
interesting to understand if Atg7 interaction with p53 is affecting to the lysosomal stability 
in our model. 
 
The relation between Atg7 and p53 is not the only one proposed as additional 
function of Atg7. In RAW264.7, a mouse macrophague cell line, Atg7 and Beclin1 are 
participating in the cell death induced by the pan-caspacase inhibitor zVAD, in fact, Atg7 
and Beclin1 knock-out cell lines presented a reduced cell death after the treatment (Yu et 
al., 2004). They proposed that Atg7 and Beclin1 were implicated in autophagic cell death, 
being this process activated when caspase 8 is inhibited with zVAD. 
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In several human tissues, Atg7 has been described as a tumor suppressor, increasing 
cell death. This could be in agreement with our hypothesis. For example, Atg7 increases 
the cell death rate, faciliting antitumor actions of obatoclax in lung cancer (McCoy et al., 
2010).  In addition, in breast cancer cell line MCF7, the deficiency of Atg7 reduces the cell 
death induced by photodynamic therapy (Xue et al., 2010). Interestingly, photodynamic 
therapy induces lysosomal damage, but the authors justify the resistance of Atg7-deficient 
cells to autophagy, although they did not study lysosomal impact. Furthermore, Atg7 has 
been described as a tumor suppressor in liver after tetrandine treatment, by increasing Atg7 
expression and enhancing autophagy, leading to ADCD (Gong et al., 2012). However, 
several publications have demonstrated that Atg7 has a role as an oncogene. For example, 
to block the Atg7-mediated autophagy augments the sensitivity of human prostate cancer 
cells (Zhu et al., 2010). Moreover, Atg7 inhibit caspase-9-dependent apoptosis in human 
colon and cervical cancer (Han et al., 2014). 
 
These findings show the diverse roles of Atg7 in different situations. Xiong 
attributed these processes due to the selective Atg7-dependent autophagy (Xiong et al., 
2015), and the response will depend on the tissue and damage. More in-depth studies are 
necessary to understand the diverse roles of Atg7. With this batch of experiments, and the 
previous experiments that show Atg7 presents a double role in cellular viability, always 
after lysosomal damage, for example after THC treatment or photodynamic therapy, we 
concluded that Atg7 may promote cell death when lysosomal function is compromised. 
 
 
5.7 LIPIDIC IMPLICATION IN LYSOSOME-DEPENDENT CELL DEATH 
 
Due to the inhibition caused by the CADs in the acid sphingomyelinase, we decided 
to study the lipid profile in the breast cancer cell line MCF7 in the parental cell line and in 
both shRNA clones knock-down for Atg7. The analysis of the lipid profile demonstrated 
several differencences in the lipid profile between the parental and the Atg7-deficient cell 
lines. More specific studies showed that Atg7-deficient cell lines presented lower amount 
of sphingomyelin species. Additionally, ceramide levels appeared to be decrease in Atg7-
deficient cell lines, except the specie Ceramide 44:1;2. 
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ASM is a water-soluble glycoprotein in charge of sphingomyeline degradation to 
ceramide. Sphingomyeline and ceramides are lipids able to influence cell survival, but the 
processes are still poorly understood. Several researchers have demonstrated that an 
increase in sphingomyelin leads to cell death. For example, during the treatment with 
camptothecin and doxorubicin of thyroid carcinoma showed a critical role of ceramide 
during cell death (Taniguchi and Okazaki, 2014). Additionally, it has been described that 
acid sphingomyelinase deficiency increases the cell death due to the lysosomal instability 
in Niemann Pick Disease (Smith and Schuchman, 2008). Interestingly, the gene encoding 
ASM, SMPD1, is decreased in gastrointestinal, hepatocellular, salivary gland, renal and 
head and neck carcinomas (Kallunki et al., 2013), suggesting the anti-apoptotic role of this 
protein. It is well known that a decrease in sphingomyelin, or a default in the acid 
sphingomyelinase reduces the lysosomal membrane stability (Pedersen et al., 2013). In 
2013, Pedersen et al., demonstrated that the acid sphingomyelinase (ASM) inhibition is 
able to destabilize cancer cell lysosomes, leading to cell death. They used siramesine and 
ASM inhibitors and observed that the interference of ASM with 
bis(monoscylglycero)phosphate (BMP) was inducing the lysosomal destability (Pedersen 
et al., 2013). The lack of ASM induces an accumulation of sphingomyelin because it is not 
transformed to ceramide. It is not the first time that the increase with sphingomyelin is 
related to cell death. For example, in Niemann Pick type A it has been described that an 
increase in sphingomyelin induced LMP and cell death (Gabandé-Rodríguez et al., 2014). 
The treatment with THC in cancer cell lines is inducing cell death and LMP due to the 
increment of dihydroceramide: ceramide ratio in the endoplasmic reticulum, leading to 
autophagosomes and triggering lysosomal membrane permeabilization (Hernández-Tiedra, 
et al., 2016) For example, ceramide is able to form rafts in the plasma membrane able to 
increase apoptosis induction (Carpinteiro et al., 2008). However, sphingomyelinase and 
ceramides are lipids able to regulate cell survival, but the processes are remaining unclear. 
 
In conclusion, we hypothethize that Atg7 could present a role related to ASM 
inhibition. In this case, cells with Atg7 would present an increase in sphingomyeline, 
promoting a sensibilization of the cells to CAD treatment. On the other hand, Atg7-
deficient cell lines would present an increase in ceramide species and a decrease in 
sphingomyeline. As commented previously, an increase in shpingomyelin species could 
display lysosomal membrane destabilization. This could explain why Atg7-deficient cell 
lines are more resistant after CAD treatment.  
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Model of Atg7 could be related to the ASM to change the lipidic profile in the lysosomes. Atg7 could be 
inhibiting the ASM activity. In that case, the amount of sphingomyelins would be higher, leading to 
lysosomal destability. When there is a deficiency of Atg7, the ASM would be increasing the levels of 
ceramide in the lysosomes, improving the lysosomal stability.  
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6. CONCLUSIONS 
1. The Rd10 mouse model presents calcium influx increase and calpain cleavage. 
This activation leads to lysosomal membrane permeabilization. Inhibition of lysosomal 
protease activity in vitro and in vivo prevents photoreceptor cell death. 
 
2. The Rd10 mice display autophagy blockade and autophagy flux block before 
neurodegeneration. Photoreceptors are the cells in the retina that present higher autophagy 
activity. 
 
3. The calcium ionophore A23187 is a suitable in vitro model to mimetize Retinitis 
pigmentosa. A23187 treatment in wild-type retinas induces intracellular calcium increase, 
autophagy blockade, lysosomal membrane permeabilization and photoreceptor cell death. 
A23187-induced cell death was rescued by blocking lysosomal activity.  
 
4. Autophagy induction with rapamycin or trehalose increases the levels of 
photoreceptor cell death in Rd10 mice. Activation of autophagy seems to be detrimental 
when lysosomal membranes are damaged. Autophagy inhibition ex vivo delays cell death.  
 
5. The cationic amphiphilic drugs ebastine, siramesine and terfenadine induce cell 
death in mouse embryonic fibroblasts. They induce cathepsin B release from lysosomes 
and lysosomal galectin-3 staining, indicative of lysosome membrane permeabilozation. 
 
6. Atg7-deficient mouse embryonic fibroblasts are more resistant to cationic 
amphiphilic drug treatment and display reduced cathepsin B release from the lysosomes to 
the cytosol compared to wild-type fibroblasts.  
 
7. Atg7-deficient mouse embryonic fibroblasts present more acidic lysosomes with 
perinuclear localization. By electronic microscopy, Atg7-deficient mouse embryonic 
fibroblasts present more electrodense particles.  
 
8. Knock-down shAtg7 in MCF7 cells present more resistance than its parental cell 
line and overexpression of Atg7 sensitizes to cell death. 
 
9. Lipidomic analysis shows that Atg7-deficient cell lines presented fewer amounts 
of sphingomyeline species, lipids that decrease lysosome stability. 
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